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Abstract: Reaction of N-alkylated imidazoles with 2-chloro-4-
quinazolinone gave mesomeric betaines, 2-(1-alkyl-1H-imid-
azolium-3-yl)quinazolin-4-olates, for which three tautomeric
forms of N-heterocyclic carbenes (NHCs) can be formulated, in
addition to an anionic NHC after deprotonation. The NHC tauto-
mers were trapped with sulfur, selenium, triethylborane, and
triphenylborane as thiones, selenones and borane adducts, re-
spectively. We obtained two isomers of the cyclic borane ad-
ducts, diazaboroloquinazolinones with [1,5-a] and [5,1-b]-type
fusion between the quinazolinone and the diazaborole rings.
1. Introduction
Since the first isolation of a stable N-heterocyclic carbene (NHC)
by Arduengo in 1991,[1] this class of compounds has developed
considerably and nowadays NHCs are ubiquitous in organic as
well as inorganic chemistry. They are widely applied in catalysis,
organocatalysis, and complex chemistry. The significance of N-
heterocyclic carbenes and of their anionic derivatives is im-
pressively demonstrated by numerous books,[2] monographs,[3]
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They correspond to two different NHC tautomers and to the
anionic NHC derived thereof. The third NHC tautomer was
trapped as a non-cyclic adduct with tris(pentafluorophenyl)-
borane by coordination to the quinazoline oxygen atom.
2D 1H-15N HMBC experiments of 15N-labeled quinazolinone
fragments, quantitative measurements of long-range 1H-15N
coupling constants (JHN), and five X-ray single crystal analyses
have been carried out for the structure elucidations and to gain
insight into the NMR spectroscopic properties of these com-
pounds.
and review articles,[4] the latest of which reflect the broad appli-
cability of this class of compounds. They deal with main group
element adducts,[5] NHCs in materials chemistry,[6] NHCs as li-
gands in cross-couplings[7] and in rhodium-catalyzed reac-
tions[8] as well as copper, nickel, and cobalt complexes.[9] The
enhancement of the σ-donating properties of N-heterocyclic
carbenes was one of the initial goals of the design of a broad
variety of interesting structures, resulting in strong donors such
as cyclic alkyl amino carbenes (CAACs)[10] and others. However,
strong NHC donation can also have divergent effects in transi-
tion-metal catalysis.[11] It has also been shown that the proper-
ties of N-heterocyclic carbenes as well as of their anionic deriva-
tives are not only governed by the donicity of their characteris-
tic σ-lone pair and the σ-framework of the parent heterocycle,
but also by their π-electronic architecture. As a result, the carb-
ene properties depend significantly on the type of conjugation
in the NHC framework.[12] For example, the negative charge of
the anionic N-heterocyclic carbene 2[13] (Scheme 1) derived
from zwitterion 1 is not delocalized in terms of resonance. It
can be classified as isolated anionic N-heterocyclic carbene. By
contrast, the mesomeric betaines 3 and the corresponding NHC
4 (imidazol-2-yliden-4-olates, X = O[14] and imidazol-2-yliden-4-
aminides, X = NR[15]) delocalize their negative charges within
the π-electron system. The same is true for the sydnone carb-
enes 6 (X = O)[16] and their sydnone imine derivatives (X =
NR)[17] generated from mesoionic precursors 5, as well as for
the ylide carbenes possessing the partial structure 8 derived
from ylides 7.[18] All anionic N-heterocyclic carbenes obtained
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by formal deprotonation from these mesomeric betaines pos-
sess conjugated π-electronic backbones with delocalized nega-
tive charges which can be located on the carbene carbon atom
itself according to the rules of resonance. Consequently, consid-
erable atomic orbital coefficients of the highest occupied
molecular orbitals (HOMO) are localized on these positions.
Thus, the π-acceptor properties of the carbene carbon atoms
are expected to change considerably in comparison to the ref-
erence imidazol-2-ylidene system. By contrast, the NHC 10[19]
derived from mesomeric betaine 9[20] is cross-conjugated, as its
anionic partial structure is π-electronically separated from the
carbene center. Therefore the influence of the π-electronic
backbone is considerably diminished in comparison to conju-
gated systems. The influence of substituent, field and resonance
effects on the ease of N-heterocyclic carbene formation from
imidazolium rings[21] and a quantitative analysis of factors influ-
encing the ease of formation as well as the σ-bonding strength
of selected oxa- and thia-N-heterocyclic carbenes[22] have been
calculated and thus give an additional impetus for further
progress in this field of chemistry.
Scheme 1. Examples of a zwitterion (1) and of mesomeric betaines (3, 5, 7,
9) as well as their N-heterocyclic carbenes.
Apart from deprotonations, decarboxylations of pseudo-
cross-conjugated mesomeric betaines such as heteroarenium-
2-carboxylates to form pyridin-2-ylidenes,[23] imidazol-2-ylid-
enes,[24] pyrazol-3-ylidenes,[25] and indazol-3-ylidenes,[26] or tau-
tomerizations of mesomeric betaines are efficient approaches
to generate N-heterocyclic carbenes in situ. Thus, the reagent
Nitron 11 has been identified as crypto-NHC as it forms metal
complexes as well as sulfur adducts from its formal NHC tauto-
mer (Scheme 2).[27] Analogous results have been achieved for
the case of the imidazolium-aminide 12.[15] In continuation of
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our interest in mesomeric betaines, N-heterocyclic carbenes
and the intersection of these two classes of compounds,[28] we
became interested in the quinazolinone core not only because
of its biological significance (alkaloids,[29] cancerostatic,[30] seda-
tive,[31] antifungal properties[32]) and applicability (e.g. as fluo-
rescent dyes[33]) but also because it enables the formation of
three different tautomers of its N-heterocyclic carbenes when a
suitable heteroarenium ring such as imidazolium is attached.
Therefore, we targeted at 4-quinazolinon-2-yl-imidazolium to
gain additional knowledge about cross-conjugated systems. Its
anionic NHC with possible sites of protonations is shown in
Scheme 2.
Scheme 2. Tautomerizations of mesomeric betaines to give N-heterocyclic
carbenes.
Herein, we report on the syntheses of our target ring system
and carbene trapping reactions with sulfur, selenium, triethyl-
borane and triphenylborane. σ-Donicities as well as π-proper-
ties have been estimated by means of 1JCSe and 1JCH coupling
constants and 77Se NMR chemical shifts. For structure elucida-
tions of the boron adducts we used a new approach based on
the analysis of long-range JHN-couplings in 2D 1H-15N spectra of
15N-labeled samples. To the best of our knowledge, the boron
adducts are the first representatives of new heterocyclic ring
systems.
2. Results and Discussion
2.1. Syntheses
The syntheses of the target molecules was smoothly accom-
plished by C–N bond formation between 2-chloroquinazolin-4-
one 14 and the N-alkylated imidazole derivatives 15a–d
(Scheme 3). Imidazole 15a was dissolved in 1,2-dichloro-
benzene (1,2-DCB), whereas all liquid azoles 15b–d reacted
without additional solvent. In the latter cases the mesomeric
betaines 13bb–d were formed in one step, whereas 15a gave
the salt 16 which was converted into the betaine 13ba by the
anion exchange resin Amberlite IRA-400 in its hydroxide form
(the index “b” stands for “mesomeric betaine”). On treatment
of the 15N-enriched chloroquinazolinone *14 (15N, 95 %) with
the imidazoles 15a,b,d the labeled salt *16 and the betaines
*13bb,d were obtained, and *16 was then converted into *13ba
in analogy to 16. Details of the synthesis of *14 starting from
1H-benzo[d][1,3]oxazine-2,4-dione and 15N-ammonium chloride
(15N, 95 %) are given in the Supporting Information. The 1H
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NMR signal of H2′imidazole is diagnostic for the betaine forma-
tion, as 16/*16 showed a signal at 10.31 ppm, whereas the
corresponding signals of the betaines 13ba–d/*13ba–c were
detected between 10.14 ppm and 9.88 ppm in [D6]DMSO, re-
spectively. No traces of the carbene tautomers 13ca–d/*13ca–c
(see Scheme 4) were detectable under these conditions (the
index “c” stands for “N-heterocyclic carbene”). The selective in-
corporation of a 15N label into the N3 position of the quin-
azoline fragment of the mesomeric betaines *13ba,b,d were
confirmed by a characteristic pattern of 13C-15N3 coupling con-
Scheme 3. Synthesis of the target betaines; 15N-labeled atoms are marked in
blue. Numbering. The index “b” stands for “mesomeric betaine”.
Scheme 4. Betaine, NHC tautomers and anionic NHC of 13.
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stants (JC-N3) and by 1D 15N NMR spectra (see Table S1 and Fig.
S2, Supporting Information). The long-range 1H-15N couplings
(JHN) with 15N labeled and unlabeled nitrogen atoms (at natural
15N abundance) were detected in the 2D 1H-15N HMBC NMR
spectra, so that we were able to unambiguously assign all sig-
nals of the betaines 13ba–d/*13ba,b,d to their corresponding
nitrogen atoms. The 15N1 and 15N3 resonances were observed
in the spectral ranges of 199–203 ppm and 208–216 ppm, re-
spectively (see Table S2 and 2D 1H-15N spectra, Supporting In-
formation).
2.2. Classification and Calculations of the Betaines and
Carbenes
The mesomeric betaines 13ba–d belong to the class of cross-
conjugated mesomeric betaines (CCMB), as the resonance
forms show no common atoms for either charge within the
common π-electron system[34] (Scheme 4). Four different tauto-
mers of 13ba–d can be formulated, three of which are the N-
heterocyclic carbenes 13ca–d-I–III. The most stable conformers
of 13bb and 13cb-I were calculated to be the syn-conformers
as shown (ΔE = 3.6 and 54.5 kJ mol–1, respectively), whereas
the anti-conformers are more stable for the case of the tauto-
mers 13cb-II and 13cb-III (ΔE = 68.3 and only 0.3 kJ mol–1, re-
spectively) according to DFT calculations (PBE0, 6-31G*). Among
these tautomers, the betaine tautomer 13bb is the most stable,
followed by NHC tautomer I (ΔE = 8.7 kJ mol–1). The anionic
N-heterocyclic carbenes 13aca–d constitute the deprotonated
form of the aforementioned species (the index “ac” stands for
“anionic N-heterocyclic carbene”). They delocalize their nega-
tive charge exclusively within the quinazolinonide moiety ac-
cording to the rules of resonance. The anti-conformer of 13acb
was found to be 7.8 kJ mol–1 more stable than its syn-conformer
in vacuo.
The JHC coupling constants of carbene precursors 13ba–d
can be taken as a measure of the σ-donor strength of the corre-
sponding NHCs.[35] We measured JH2′-C2′ coupling constants
between 225.7 Hz (13bc) and 226.3 Hz (13ba) (Table S3 and
Fig. S3, Supporting Information) which resemble the value of
1,3-dimesitylimidazol-2-ylidene (JH2′-C2′ = 225 Hz). A comparison
between 13ba–d and the salt 16 can rule out contributions
of intramolecular hydrogen bonds between C2′H and N3 in
solution which might cause slightly increased values for the
1JH2′-C2′ coupling constants,[36] as the values of the betaines and
the salt are very similar. Thus, a coupling constant of 227.5 Hz
was detected in 16, which cannot form the aforementioned
hydrogen bond.
The weak electron-donating effect of the anionic substituent
is also well reflected in the calculated frontier orbitals of the
model compound 13bb (Figure 1), because the cationic frag-
ment is joined via a nodal position of the highest occupied
molecular orbital (HOMO) to the anionic fragment. This is char-
acteristic of cross-conjugated systems. The HOMO of the NHC
tautomer 13cb-I is a π-orbital with considerable atomic orbital
coefficients in the quinazolinonide substituent. As the system is
planar in vacuo according to the calculation some small coeffi-
cients on N1′ and the carbene carbon atom C2′ have also been
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found. The HOMO-1 shows the characteristic σ-lone pair of the
NHC, and its lowest unoccupied molecular orbital (LUMO) pos-
sesses a considerable atomic orbital coefficient on the carbene
carbon atom. The tautomers 13cb-II and 13cb-III differ slightly
in their frontier orbital geometries and energies (see Fig. S7,
Supporting Information). The HOMO of the anionic NHC 13acb
resembles the HOMO of the betaine with respect to its geome-
try. Interestingly, the HOMO-1 combines the σ-lone pair of the
NHC with the σ-framework of the anionic fragment of the quin-
Figure 1. Selected frontier orbitals.
Figure 2. Comparison of relevant frontier orbital energies of the three tauto-
mers 13cb-I–III and the anionic NHC 13acb with extremely π-electron poor
and π-electron rich NHCs as well as 1,3-dimethylimidazol-2-ylidene as refer-
ence compound.
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azolinonide substituent including the free electron pairs of the
nitrogen and oxygen atoms.
The type of conjugation is also well reflected in the HOMO/
LUMO energies. We think that the Eσ energy of 13acb is lower
than those of anionic conjugated N-heterocyclic carbenes such
as sydnone carbenes[16] or the extremely π-electron-rich conju-
gated molsidomine carbene,[17] which we reported earlier, due
to the cross-conjugation which induces a π-electronic isolation
of the negatively charged substituent with respect to the fron-
tier orbitals. An additional reason might be the better meso-
meric stabilization of the anionic charge. A comparison of the
HOMO/LUMO energies of the cationic NHC derived from imid-
azo[4,5-b]pyridinium,[37] of the 13 series reported here, of the
reference NHC 1,3-dimethylimidazol-2-ylidene, and the conju-
gated anionic sydnone carbene[16] is displayed in Figure 2.
These examples of NHCs cover the range from extremely π-
electron poor to extremely π-electron rich.
2.3. Betaine–Carbene Transformations and Trapping
Reactions
On treatment of the mesomeric betaines 13ba–d with sulfur
and selenium, respectively, the adducts 17a–d and 18a–d of
the tautomeric carbenes 13ca–d-I were obtained in 18–72 %
yield (Scheme 5). The 77Se NMR chemical shifts have been first
utilized by Ganter et al. to determine the π-acceptor strengths
of NHCs within the adducts[38] and the method has been ap-
plied to numerous NHCs since then.[39] The selenium atoms
appear as singlets between 100.57 ppm (18a), 104.74 ppm
(18c) and 120.85 ppm (18b) in the 77Se NMR spectra which is
indicative of weak π-acceptor capabilities. The values are similar
to those of 1,3-dimesitylimidazol-2-ylidene (δSe = 116 ppm).[35]
The corresponding 1JCSe coupling constants were found to be
237 Hz (18a), 236 Hz (18b), and 237 Hz (18c) (Table S4,
Scheme 5. Trapping reactions of the carbene tautomer with S and Se.
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Fig. S4, Supporting Information). These values are indicative of
σ-donicities which resemble those of 1,3-di(isopropylphenyl)-
4,5-dichloro-imidazol-2-ylidene (239 Hz).[35] We were able to
grow single crystals of 17a and to perform an X-ray crystal
structure analysis the molecular drawing of which is shown in
the Supporting Information (Fig. S8, Supporting Information).
The analysis of this structure revealed an interatomic distance
between H3 and the sulfur in position 2′ of 2.205 Å which is
significantly smaller than the sum of the van der Waals radii of
the corresponding atoms (≈ 3 Å). This indicates the formation
of a N3–H···S=C2′ hydrogen bond in the solid state. However,
the moderate downfield-shift of the H3 resonances frequencies
observed for the case of the sulfur and selenium adducts
[δH between 13.71 (18a) and 14.13 (17b) ppm] in comparison
to the corresponding value of compound *14 (13.27 ppm),
where such H-bonding is not possible, cannot confirm signifi-
cant hydrogen bonds in solution. The presence of hydrogen
bonds influences δSe values. We think that their influences are
negligible here in view of the very large chemical shift range
from 0 to 850 ppm[35] of 77Se resonance frequencies in selen-
ium-NHC adducts.
Triethylborane converted the mesomeric betaines 13ba–d at
200 °C in anhydrous dioxane into the cyclic borane adducts
19a–d and 20c,d, respectively (Scheme 6). The reaction of
13ba,bwithtriethylboraneledexclusivelytotheimidazo[2′,1′:3,4]-
[1,4,2]diazaborolo[5,1-b]quinazolin-12-ides 19a,b, whereas
13bc,d gave mixtures of the separable [5,1-b] and [1,5-a] iso-
mers 19c,d and 20c,d in ≈ 3.6:1 and ≈ 3.1:1 ratios under analo-
gous conditions, respectively. Triphenylborane reacted similary
to give 21a–d and 22c,d. The separable isomers 21c,d and
22c,d were formed in ratios of ≈ 1:2.1 and ≈ 1.3:1, respectively.
The isomers correspond to the NHC′s tautomeric forms 13ca–
d-I and 13ca–d-II shown in Scheme 4. To the best of our knowl-
edge they are first representatives of new heterocyclic ring sys-
tems and are formal trapping adducts of the anionic NHC
13aca–d. The formation of the borane adducts 19a–d and 20c,d
was confirmed by the appearance of signals in the range from
1.1 ppm to –0.8 ppm in the 1D 11B NMR spectra, and of 21a–d
and 22c,d between –1.80 ppm and –2.62 ppm which is the
typical range of 11B resonance frequencies of carbene ad-
ducts.[28] The resonances of the 11B nuclei and signals of the
neighbouring 13C nuclei in the 2′ and 1′′ positions were signifi-
cantly broadened, probably due to the presence of the negative
partial charge of the boron atom as indicated by the alternative
representations shown in Scheme 5. This made the observation
of 11B J-couplings impossible. The structure of the compounds
19a–d and 20c,d, however, was unambiguously elucidated by
analysis of the JHN-couplings in the 2D 1H-15N HMBC NMR ex-
periments which were recorded for samples with natural iso-
topic abundance of 15N nuclei in [D6]DMSO solution (see 2D
1H-15N HMBC spectra, Supporting Information). The spectra of
the isomers 20c,d showed two cross-peaks corresponding to
the vicinal 3JH8-N1 and 3JH1′′-N1 couplings which confirm the cy-
clization via N1 (Figure 3). The nitrogen atoms of the quin-
azoline moiety of 19a–d were first assigned by their 1H-15N
coupling constants, then the 3JH1′′-N3 and 3JH8-N1 couplings con-
firmed their [1,5-a]-fusion.
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Scheme 6. Adduct formation via oxygen.
Figure 3. Numbering and diagnostic JHN-couplings.
The NMR-derived structures of the compounds 19a–d in
[D6]DMSO are in agreement with X-ray diffraction data which
are obtained for the adduct 19b (Figure 4). Suitable crystals for
an X-ray structure analysis were obtained by slow evaporation
of a concentrated solution in ethyl acetate. The compound crys-
tallized in the monoclinic space group P21/c. The bond lengths
between the boron atom and the former carbene carbon atom/
quinazoline nitrogen (B1–C3/B1–N3, crystallographic number-
ing) were determined to be 1.626(3) Å/1.627(2) Å. The bond
lengths between the boron atom and the methylene carbon
atoms of the ethyl groups were 1.620(3) Å. The four rings benz-
ene, pyrimidine, diazaborole, and imidazole were almost planar.
Torsion angles C11–N2–C2–N1 = –3.2(3)°, C10–N1–C2–N3 =
0.1(3)°, C3–N2–C2–N3 = –0.3(2)°, N3–C4–C5–C10 = 1.4(3)° were
measured.
Figure 4. ORTEP diagram of the X-ray structure of compound 19b.
As recently reviewed,[40] selective 15N-labeling is highly effi-
cient for structure elucidations. As the absence of hydrogen
atoms attached to C1′′ of 21 and 22 prevented cross-peaks in
HMBC measurements, we prepared *21a,b,d and *22d possess-
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ing 15N labels at the N3 positions from *13a,b,d (Figure 5). Thus,
the detection of long-range 1H-15N3 interactions in the 2D 1H-
15N HMBC spectra and quantitative measurements of the corre-
sponding JHN3 (Figures S5 and S6, Supporting Information) as
well as of the diagnostic 13C-15N3 J-coupling constants was pos-
sible (Fig. S1, Supporting Information).
Figure 5. Diagnostic JHN and JCN couplings confirmed structures of the 15N-
labeled NHC-borane adducts *21a,b,d and *22d. The JHN couplings observed
only in 2D 1H-15N-HMBC spectra are shown by green arrows. The blue and
gray arrows show JH-N3 > 0.05 Hz, for which quantitative measurements were
possible. The measured 3JC2′′-N3 couplings are shown by a red arrow.
The observed 4JH-N3 and 3JC-N3 coupling constants (≈ 0.2 and
≈ 0.6 Hz, respectively) with the H2′′ and C2′′ atoms in ortho-
position of the phenyl substituents of *21a,b,d unambiguously
proved the cyclization via the 15N3-atom (Figure 5, [5,1-b]-type
of fusion). At the same time, the absence of detectable JHN
and JCN couplings between 15N3 and atoms of the phenyl rings
implied that the cyclization of *22d occurred through the N1
atom ([1,5-a]-type of fusion). The small amplitude of 1JBN cou-
plings (expected value ≈ 1.5 Hz) and relatively large linewidth
of the 15N3 resonances, however, did not allow to measure
11B-15N spin-spin interactions in the compounds *21a,b, de-
spite of our expectations based on published results.[41] In the
parent betaines 13ba–d the 15N1 and 15N3 nuclei resonated in
regions around 200 and 215 ppm, respectively. It is interesting
to note that the cyclization via the N3 atom (compounds 19a–
d and 21a–d) does not influence significantly the 15N1 chemical
shifts, but induces an upfield shift of approximately 40 ppm of
the 15N3 atoms to ca. 175 ppm (see Fig. S2 and Table S2, Sup-
porting Information). Contrary to that, the cyclization through
the N1 atom in compounds 20c,d and 22c,d does not change
the chemical shifts of the 15N3 atom, whereas the signals of
15N1 atom shift upfield by ≈ 50 ppm to approximately 150 ppm.
The structures of the isomeric adducts 21a and 22d were
also proved by X-ray crystallographic analyses (Figure 6). Suit-
able single crystals of 21a and 22d were obtained by slow
evaporation of concentrated solutions in acetonitrile. Com-
pound 21a crystallized with one molecule of acetonitrile in the
triclinic space group P1, whereas 22d crystallized in the mono-
clinic space group P21/c. The B–C1 carbene bond lengths (crys-
tallographic numbering) were determined to be 1.643(2) Å
(21a) and 1.619(3) Å (22d), respectively, which is slightly shorter
than those of other boron adducts.[28c] The bond lengths be-
tween the boron atom and the nitrogen atom N3 and N1 in
21a and 22d were found to be 1.618(2) and 1.620(3) Å, respec-
tively. The torsion angles between imidazole and the quin-
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azoline fragment C1–N2–C2–N1 (21a) and N1–C2–N3–C4 (22d)
were determined to be –179.08(14)° and –1.7(3)°. These data
confirmed that the quinazoline, diazaborole, and imidazole
fragments of 21a and 22d are almost planar.
Figure 6. ORTEP diagrams of the X-ray structures of compounds 21a (a,
above) and 22d (b, below).
Finally, we were also able to form adducts via the oxygen
atom of the betaines. Thus, tris(pentafluorophenyl)borane in di-
oxane at room temperature reacted with 13ba–c to give the
borates 23a–c in 56 %, 48 % and 20 % yields, respectively
(Scheme 6).
The attachment of the pentafluorophenyl substituent was
confirmed by a 2D 1H-19F HOESY spectrum measured for com-
pound 23b. The spectrum revealed dipolar interactions be-
tween the 19F2′′ nuclei of the pentafluorophenyl and 1H5 as
well as 1H4′, and overlapped 1H6/1H5′ signals of the heterocy-
clic moiety (Figure 7 and see Figure S135, Supporting Informa-
tion). The 15N chemical shifts provide additional information
about the structure of 23b. In this case the 15N1 and 15N3 reso-
nances demonstrated only weak downfield shifts relative to the
parent betaine 13bb. They have chemical shifts of ≈ 224 ppm
and ≈ 220 ppm, respectively (Table S2 and Fig. S2, Supporting
Information). The resonance frequencies of N1′ and N3′ of the
imidazole ring also remained essentially unchanged. Thus, the
attachment of the boron substituent does not affect the nitro-
gen atoms, keeping only one possibility of attachment through
the oxygen atom.
The NMR analyses were supported by the results of single-
crystal X-ray crystallography (Figure 8). Suitable crystals of 23b
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Figure 7. Dipolar 1H, 19F interactions for structure elucidation.
were obtained by slow evaporation from dioxane. The com-
pound 23b crystallized with 2.5 molecules of 1,4-dioxane in the
triclinic space group P1¯. The boron atom is surrounded by three
carbon atoms of three pentafluorophenyl rings and one oxygen
atom of the ligand. The B–C bonds were found to be 1.643(3),
1.644(3), and 1.649(3) Å, which correspond to the values of the
bond lengths in the literature-known tris(perfluorophenyl)-
borate of 2-(3-alkyl-1H-imidazolium-1-yl)phenolates.[42] The
B–O bond has a length of 1.522(3) Å. This is in analogy to the
B–O distance of B(C6F5)3 adducts of formate (1.532 Å),[43] or 2-
(pyridin-2-yl)phenol (1.520 Å).[44] The polyhedron BC3O is tetra-
hedral with bond angles C–B1–O1 and C–B1–C in the range of
103.1(2)–112.0(2)° and 106.3(2)–114.6(2)°, respectively.
Figure 8. ORTEP diagram of the X-ray structure of borane adduct 23b.
Conclusions
The mesomeric betaines 2-(1-alkyl-1H-imidazolium-3-yl)quinaz-
olin-4-olates are cross-conjugated and crypto-N-heterocyclic
carbenes. The latter can be formulated as three different tauto-
mers or as anionic N-heterocyclic carbene after deprotonation.
Imidazole-2-thiones and imidazole-2-selenones were obtained
on reaction of sulfur and selenium, respectively, with the beta-
ines, which behave as N-heterocyclic carbenes under these con-
ditions. The usage of triethylborane and triphenylborane led to
new cyclic borane adducts, imidazo[2′,1′:3,4][1,4,2]diazaborolo-
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[5,1-b]quinazoline-12-ides and their [1,5-a]-isomers. These are
formal trapping products of the anionic NHC and represent the
translation of different tautomers into new structures of cyclic
borane adducts. Structures were confirmed by analysis of
1H-15N J-couplings and 15N chemical shifts at natural isotopic
abundance and upon selective 15N-labeling of the N3 position
in the 4-oxoquinazolinide fragment. The 15N chemical shift data
and through-space dipolar correlations observed in 2D 1H-19F
HOESY spectra turned out to be useful for the identification of
noncyclic adducts containing pentafluorophenyl groups. The
σ-donating and π-accepting properties of the N-heterocyclic
carbenes were estimated by analysis of 1JCSe and 1JHC coupling
constants as well 77Se resonance frequencies. In accordance
with their classification as cross-conjugated systems and in con-
trast to conjugated systems, the anionic substituent takes only
a weak influence on the characteristics of the corresponding
NHCs. These results supplement on the one hand our knowl-
edge about the intersection of the two substance classes of
N-heterocyclic carbenes and mesomeric betaines which are
crypto-NHCs depending on their type of conjugation, and on
the other hand our knowledge about boron adducts of
NHCs.[45]
Experimental Section
All reactions were carried out under an atmosphere of nitrogen in
flame or oven-dried glassware. All chemicals were purchased and
used without further purification unless otherwise mentioned. An-
hydrous solvents were dried according to standard procedures be-
fore usage. Melting points are uncorrected and were determined
in an apparatus according to Dr. Tottoli (Büchi). The ATR-IR
spectra were obtained on a Bruker Alpha in the range of 400 to
4000 cm–1. 1H, 11B, 13C, 15N, 19F and 77Se NMR spectra were meas-
ured in [D6]DMSO solution using Bruker AVANCE-II-400 or Bruker
NEO 600 spectrometers equipped with room temperature broad-
band probes, or using a Bruker AVANCE-700 spectrometer equipped
with a triple-resonance (1H, 13C, 15N) room-temperature probe. 1H
chemical shifts were referenced to the DMSO signal which appeared
at 2.50 ppm. Chemical shifts of 11B, 13C, 15N, 19F, and 77Se nuclei
were referenced indirectly relative to boron trifluoride etherate,
Me4Si, liquid ammonium, CCl3F and Me2Se, respectively. Multiplici-
ties are described by using the following abbreviations: s = singlet,
d = doublet, t = triplet, q = quartet, and m = multiplet. The assign-
ment of all 1H and 13C resonances was achieved using gradient
enhanced versions of 2D NMR 1H-13C HSQC, and 1H-13C HMBC ex-
periments. The assignment of 15N atoms (labeled or at natural
abundance) was based on 2D 1H-15N HMBC experiments. The meas-
urements of JH-C, JH-N, JC-N and JC-Se coupling constants are de-
scribed in the Supporting Information. The mass spectra (ESIMS)
were measured with a Varian 320 MS Triple Quad GC/MS/MS (EIMS)
or with an Agilent LCMSD series HP 1100 with APIES at fragmentor
voltages as indicated. Samples were sprayed from MeOH at 4000 V
capillary voltage and fragmentor voltages of 30 V unless otherwise
noted. The HRMS spectra were obtained with a Bruker Impact II, a
Bruker Daltonik Tesla–Fourier transform-ion cyclotron resonance
mass spectrometer, or with a Waters Micromass LCT with the direct
inlet. Chromatography: The reactions were traced by thin layer chro-
matography with silica gel 60 (F254, company MERCK KGAA). For
the detection of substances, quenching was used at either 254 nm
or 366 nm with a mercury lamp. The preparative column chroma-
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tography was conducted through silica gel 60 (230 400 mesh) of
the company MERCK KGAA. Yields are not optimized.
Crystal Structure Determinations
The X-ray diffraction data of the compounds 17a, 19b, 21a and
22d were collected on a Xcalibur S diffractometer with Mo-Kα radia-
tion (λ = 0.71073 Å, graphite monochromator, ω/2θ-scanning tech-
nique). Unit cell parameters were refined using all collected spots
after the integration process. The structures were solved by direct
methods that were implemented in the SHELXS-97 program.[46] The
refinements were carried out through full-matrix anisotropic least-
squares methods on F2 for all reflections of the non-H atoms using
the SHELXL-97 program.[47] The single-crystal X-ray diffraction stud-
ies of compound 23b were carried out on a Bruker SMART APEX II
diffractometer equipped with a CCD detector (Mo-Kα, λ = 0.71073 Å,
graphite monochromator). Semiempirical absorption correction was
applied.[48] The structures were solved by direct methods and re-
fined by the full-matrix least-squares with anisotropic displacement
parameters using the SHELX-2014 program package.[49] The
hydrogen atoms of the ligands were positioned geometrically and
refined using the riding model.
CCDC 1938079 (for 17a), 1938188 (for 19b), 1938147 (for 21a),
1938162 (for 22d), and 1917533 (for 23b) contain the supplemen-
tary crystallographic data for this paper. These data can be obtained
free of charge from The Cambridge Crystallographic Data Centre.
17a: Colorless crystals, C18H14N4OS, M = 334.39, crystal size
0.45 × 0.35 × 0.25 mm, monoclinic system, space group P2(1)/c,
a = 7.3155(10) Å, b = 23.103(3) Å, c = 9.8773(15) Å, α = 90.00°,
 = 110.912(13)°, γ = 90°, V = 1559.4(4) Å3, Z = 4, ρcalc = 1.424 g cm–3,
μ = 0.220 cm–1, 8796 measured reflections, 1688 reflections with
I > 2.0σ(I), Rint = 0.0398, GooF = 1.007, R1 [I > 2σ(I)] = 0.0395, wR2
[I > 2σ(I)] = 0.0614, R1 (all data) = 0.0989, wR2 (all data) = 0.0646,
Tmin/max = 0.8364/1.1692.
19b: Colorless crystals, C16H19BN4O, M = 294.16, crystal size
0.48 × 0.36 × 0.24 mm, monoclinic system, space group P2(1)/c, a =
7.3715(5) Å, b = 12.8142(8) Å, c = 16.7820(14) Å, α = 90°,  =
92.686(6)°, γ = 90°, V = 1583.5(2) Å3, Z = 4, ρcalc = 1.234 g cm–3,
μ = 0.079 cm–1, 9474 measured reflections, 2437 reflections with
I > 2.0σ(I), Rint = 0.0336, GooF = 1.004, R1 [I > 2σ(I)] = 0.0573, wR2
[I > 2σ(I)] = 0.1518, R1 (all data) = 0.1047, wR2 (all data) = 0.2039,
Tmin/max = 0.7537/1.0000.
21a: Colorless crystals, C32H26BN5O, M = 507.39, crystal size
0.49 × 0.38 × 0.26 mm, triclinic system, space group P1¯, a =
11.0751(7) Å, b = 11.4438(8) Å, c = 11.7557(8) Å, α = 69.231(6)°,  =
72.687(6)°, γ = 83.101(5)°, V = 1329.82(15) Å3, Z = 2, ρcalc =
1.267 g cm–3, μ = 0.078 cm–1, 10466 measured reflections, 4344
reflections with I > 2.0σ(I), Rint = 0.0265, GooF = 1.008, R1 [I > 2σ(I)] =
0.0540, wR2 [I > 2σ(I)] = 0.1472, R1 (all data) = 0.0894, wR2 (all data) =
0.1869, Tmin/max = 0.7927/1.0000.
22d: Colorless crystals, C26H21BN4O, M = 416.28, crystal size
0.41 × 0.33 × 0.20 mm, monoclinic system, space group P2(1)/c, a =
14.3210(16) Å, b = 9.3202(7) Å, c = 16.4475(15) Å, α = 90.00°,  =
98.942(10)°, γ = 90°, V = 2168.6(4) Å3, Z = 4, ρcalc = 1.275 g cm–3,
μ = 0.079 cm–1, 14741 measured reflections, 2802 reflections with
I > 2.0σ(I), Rint = 0.0526, GooF = 1.000, R1 [I > 2σ(I)] = 0.0593, wR2
[I > 2σ(I)] = 0.1291, R1 (all data) = 0.1446, wR2 (all data) = 0.1797,
Tmin/max = 0.8001/1.0000.
23b: Colorless crystals, C40H30BF15N4O6, M = 958.49, colorless,
parallelepiped, crystal size 0.30 × 0.20 × 0.10, triclinic system, space
group P1¯, a = 11.0423(3) Å, b = 12.3276(3) Å, c = 16.2662(4) Å, α =
73.3220(10)°,  = 71.0790(10)°, γ = 78.0130(10)°, V = 1990.36(9) Å3,
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Z = 2, ρcalc = 1.599 g cm–3, μ = 0.154 cm–1, 18405 measured reflec-
tions, 6664 reflections with I > 2.0σ(I), Rint = 0.0226, GooF = 1.030,
R1 [I > 2σ(I)] = 0.0508, wR2 [I > 2σ(I)] = 0.1357, R1 (all data) = 0.0616,
wR2 (all data) = 0.1434, Tmin/max = 0.661/0.745.
Calculations
All density-functional theory (DFT)-calculations were carried out ap-
plying the current Spartan Software (Spartan'18, Wavefunction, Inc.,
Irvine, CA. Available from: http://www.wavefun.com) running on an
Intel® CoreTM i7–6950X decacore system equipped with 64 GB RAM
main memory and sufficient solid-state disc space. MM2 optimized
structures were used as starting geometries. Complete geometry
calculations were performed with the PBE0 density functional and
the implemented 6-31G* basis set in order to allow for comparison
with previous results. All final structures were proven to be true
minima by the absence of imaginary frequencies.
Synthesis
Compound 14 was prepared according to previously published
protocols.[50] The synthesis of *14 is presented in the Supporting
Information.
2-(1-Benzyl-1H-imidazolium-3-yl)quinazolin-4-olate (13ba): A
150 mL portion of the anion-exchange resin Amberlite IRA-400 was
filled into a column (height: 16 cm, diameter: 3 cm) and washed
with 2 L of water. Then 100 mL of a 5 % hydrochloric acid solution
was added and remained in the column for 2 h. The hydrochloric
acid was then rinsed out with water until pH 7 was reached. 100 mL
of a 5 % aqueous solution of sodium hydroxide was added and
remained in the column for 2 h. Then the base was rinsed out with
water until pH = 7 was reached. Then, samples of salts 16 (0.677 g,
2.0 mmol) in 60 mL of water were added on the resin. After that,
the resulting betaine was extracted with ethyl acetate and solvent
was evaporated in vacuo. Yield 0.508 g, 84 %, colorless solid, m.p.
> 252 °C (dec.). 1H NMR (600 MHz, [D6]DMSO): δ = 5.51 (s, 2H, H6′
), 7.25 (ddd, 1J = 7.9 Hz, 2J = 6.9 Hz, 3J = 1.1 Hz, 1H, H6), 7.38–7.45
(m, 3H, H9′,H10′), 7.46 (ddd, 1J = 8.2 Hz, 2J = 1.1 Hz, 3J = 0.5 Hz, 1H,
H8), 7.52–7.54 (m, 2H, H8′), 7.56 (ddd, 1J = 8.3 Hz, 2J = 6.9 Hz, 3J =
1.5 Hz, 1H, H7), 7.86 (t, 1J = 1.86 Hz, 1H, H4′), 8.00 (ddd, 1J = 7.9 Hz,
2J = 1.5 Hz, 3J = 0.4 Hz, 1H, H5), 8.32 (t, 1J = 1.83 Hz, 1H, H5′), 10.13
(d, 1J = 1.6, 1H, H2′) ppm. 13C NMR (151 MHz, [D6]DMSO): δ = 52.29
(C6′), 119.32 (C5′), 122.60 (C4′), 122.85 (C4a), 123.53 (C6), 125.39
(C8), 126.25 (C5), 128.48 (C8′), 128.80 (C10′), 129.03 (C9′), 131.69
(C7), 134.81 (C7′), 134.9 (C2′), 150.60 (C8a), 151.96 (C2), 171.33 (C4)
ppm. IR (ATR): ν˜ = 3024, 1580, 1530, 1472, 1450, 1367, 1077, 1029,
926, 768, 744, 695, 631 cm–1. HRMS (ESI) m/z calcd. for C18H14N4ONa
[M + Na]+ 325.1065, found 325.1058; elemental analysis calcd. (%)
for C18H14N4O: C 71.51, H 4.67, N 18.53; found C 71.41, H 4.55, N
18.78.
[3-15N]-2-(1-Benzyl-1H-imidazolium-3-yl)quinazolin-4-olate
(*13ba): Synthesized as described for 13a. Yield 0.181 g, 60 %, col-
orless solid, m.p. > 252 °C (dec.). 1H NMR (600 MHz, [D6]DMSO): δ =
5.51 (s, 2H, H6′), 7.25 (ddd, 1J = 7.9 Hz, 2J = 6.9 Hz, 3J = 1.1 Hz, 1H,
H6), 7.38–7.45 (m, 3H, H9′,H10′), 7.46 (ddd, 1J = 8.2 Hz, 2J = 1.1 Hz,
3J = 0.5 Hz, 1H, H8), 7.52–7.54 (m, 2H, H8′), 7.56 (ddd, 1J = 8.3 Hz,
2J = 6.9 Hz, 3J = 1.5 Hz, 1H, H7), 7.86 (t, 1J = 1.86 Hz, 1H, H4′), 8.00
(ddd, 1J = 7.9 Hz, 2J = 1.5 Hz, 3J = 0.4 Hz, 1H, H5), 8.32 (t, 1J = 1.7 Hz,
1H, H5′), 10.13 (s, 1H, H2′) ppm. 13C NMR (151 MHz, [D6]DMSO): δ =
52.27 (C6′), 119.30 (d, 3J = 1.5 Hz, C5′), 122.58 (C4′), 122.86 (d, 2J =
2.4 Hz, C4a), 123.49 (C6), 125.37 (C8), 126.23 (br. s, C5), 128.48
(C8′), 128.79 (C10′), 129.03 (C9′), 131.66 (C7), 134.82 (C7′), 134.90 (d,
3J = 2.5 Hz, C2′), 150.59 (C8a), 151.95 (d, 1J = 4.6 Hz, C2), 171.25 (d,
1J = 4.3 Hz, C4) ppm. IR (ATR): ν˜ = 3024, 1580, 1530, 1472, 1450,
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1367, 1077, 1029, 926, 768, 744, 695, 631 cm–1. HRMS (ESI) m/z
calcd. for C18H1415NN3ONa [M + Na]+ 326.1036, found 326.1034.
General Procedure for the Synthesis of the Betaines 13bb, 13bd:
Under an inert atmosphere a mixture of 2-chloroquinazolin-4(3H)-
one (180 mg, 1.0 mmol) and 2 equiv. excess of corresponding imid-
azoles (2.0 mmol) was stirred at 100–105 °C for 2 h without solvent.
After stirring mixture was cooled to r.t., added CHCl3 (13bb) or diox-
ane (13bd), then the resulting precipitates were filtered off, washed
with a small amount of CHCl3 (13bb) or dioxane (13bd) and dried.
2-(1-Methyl-1H-imidazolium-3-yl)quinazolin-4-olate (13bb): 1-
Methylimidazole (161 μL, 2.0 mmol) was used. Recrystallization from
iPrOH gave 13bb. Yield 0.150 g, 67 % colorless solid, m.p. > 198 °C
(dec.). 1H NMR (600 MHz, [D6]DMSO): δ = 3.94 (s, 3H, H6′), 7.26 (t,
1J = 7.4 Hz, 1H, H6), 7.46 (d, 1J = 8.0 Hz, 1H, H8), 7.57 (t, 1J = 7.4 Hz,
1H, H7), 7.78 (s, 1H, H4′), 8.01 (dd, 1J = 7.9 Hz, 2J = 1.0 Hz, 1H, H5),
8.29 (t, 1J = 1.6 Hz, 1H, H5′), 9.88 (s, 1H, H2′) ppm. 13C NMR
(151 MHz, [D6]DMSO): δ = 36.10 (C6′), 118.60 (C5′), 122.68 (C4a),
123.60 (C6), 123.88 (C4′), 125.41 (C8), 126.22 (C5), 131.79 (C7),
135.46 (C2′), 150.55 (C8a), 151.72 (C2), 171.13 (C4) ppm. IR (ATR):
ν˜ = 3390, 3086, 1592, 1576, 1541, 1471, 1349, 1268, 1112, 1077,
926, 846, 775, 698, 617 cm–1. HRMS (ESI) m/z calcd. for C12H10N4ONa
[M + Na]+ 249.0752, found 249.0746.
[3-15N]-2-(1-Methyl-1H-imidazolium-3-yl)quinazolin-4-olate
(*13bb): Synthesized as described for 13bb. Yield 0.158 g, 70 %,
colorless solid, m.p. > 198 °C (dec.). 1H NMR (600 MHz, [D6]DMSO):
δ = 3.96 (s, 3H, H6′), 7.34 (t, 1J = 7.1 Hz, 1H, H6), 7.53 (d, 1J = 8.1 Hz,
1H, H8), 7.66 (t, 1J = 7.4 Hz, 1H, H7), 7.83 (s, 1H, H4′), 8.05 (dd, 1J =
7.9 Hz, 2J = 1.0 Hz, 1H, H5), 8.31 (t, 1J = 1.6 Hz, 1H, H5′), 9.92 (s, 1H,
H2′) ppm. 13C NMR (151 MHz, [D6]DMSO): δ = 36.22 (C6′), 118.81
(C5′), 121.89 (br. s, C4a), 124.05 (C6), 124.50 (C4′), 125.71 (C8), 126.15
(C5), 132.62 (C7), 135.73 (C2′), 150.01 (C8a), 150.06 (d, 1J = 6.9 Hz,
C2), 169.93 (d, 1J = 5.7 Hz, C4) ppm. IR (ATR): ν˜ = 3390, 3086, 1592,
1576, 1541, 1471, 1349, 1268, 1112, 1077, 926, 846, 775, 698,
617 cm–1. HRMS (ESI) m/z calcd. for C12H1015NN3ONa [M + Na]+
250.0723, found 250.0722.
2-(1-Butyl-1H-imidazolium-3-yl)quinazolin-4-olate (13bc): Under
an inert atmosphere a mixture of 2-chloroquinazolin-4(3H)-one
(180 mg, 1.0 mmol) and 2 equiv. excess of 1-butylimidazole (262 μL,
2.0 mmol) was stirred at 100–105 °C for 2 h without solvent. After
stirring mixture was cooled to r.t., the resulting mixture was purified
by column chromatography (silica gel, elution gradient ethyl acet-
ate → ethyl acetate/MeOH, 5:1). Yield 0.145 g, 54 %, colorless solid,
m.p. 174 °C. 1H NMR (600 MHz, [D6]DMSO): δ = 0.92 (t, 1J = 7.4 Hz,
3H, H9′), 1.33–1.25 (m, 2H, H8′), 1.88–1.82 (m, 2H, H7′), 4.28 (t, 1J =
7.2 Hz, 2H, H6′), 7.28–7.25 (m, 1H, H6), 7.47 (d, 1J = 7.7 Hz, 1H, H8),
7.58 (ddd, 1J = 8.4 Hz, 2J = 7.0 Hz, 3J = 1.6 Hz, 1H, H7), 7.90 (t, 1J =
1.8 Hz, 1H, H4′), 8.01 (dd, 1J = 7.9 Hz, 2J = 1.2 Hz, 1H, H5), 8.33 (t,
1J = 1.8 Hz, 1H, H5′), 9.97 (s, 1H, H2′) ppm. 13C NMR (151 MHz,
[D6]DMSO): δ = 13.29 (C9′), 18.83 (C8′), 31.27 (C7′), 48.94 (C6′),
118.96 (C5′), 122.61 (C4′), 122.68 (C4a), 123.61 (C6), 125.41 (C8),
126.22 (C5), 131.80 (C7), 134.87 (C2′), 150.53 (C8a), 151.71 (C2),
171.13 (C4) ppm. IR (ATR): ν˜ = 3211, 3079, 3015, 2955, 1531, 1501,
1454, 1378, 1337, 1276, 1153, 1083, 1028, 921, 769, 690, 636 cm–1.
HRMS (ESI) m/z calcd. for C15H16N4ONa [M + Na]+ 291.1222, found
291.1220.
2-(1-Allyl-1H-imidazolium-3-yl)quinazolin-4-olate (13bd): 1-Allyl-
imidazole (216 μL, 2.0 mmol) was used. Recrystallization from iPrOH
gave 13bd. Yield 0.190 g, 75 %, colorless solid, m.p. > 260 °C (dec.).
1H NMR (600 MHz, [D6]DMSO): δ = 4.94 (d, 1J = 6.0 Hz, 2H, H6′),
5.35–5.39 (m, 2H, H8′), 6.13 (ddt, 1J = 16.4 Hz, 2J = 10.3 Hz, 3J =
6.1 Hz, 1H, H7′), 7.25 (ddd, 1J = 8.0 Hz, 2J = 7.0 Hz, 3J = 1.2 Hz, 1H,
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H6), 7.47 (dd, 1J = 8.2 Hz, 2J = 0.6 Hz, 1H, H8), 7.57 (ddd, 1J = 8.4 Hz,
2J = 7.0 Hz, 3J = 1.6 Hz, 1H, H7), 7.80 (t, 1J = 1.9 Hz, 1H, H4′), 8.00
(dd, 1J = 7.9 Hz, 2J = 1.2 Hz, 1H, H5), 8.34 (t, 1J = 1.8 Hz, H5′), 9.94
(t, 1J = 1.6 Hz, 1H, H2′) ppm. 13C NMR (151 MHz, [D6]DMSO): δ =
51.20 (C6′), 119.03 (C5′), 120.36 (C8′), 122.63 (C4′), 122.81 (C4a),
123.53 (C6), 125.38 (C8), 126.24 (C5), 131.70 (C7), 131.84 (C7′),
134.94 (C2′), 150.58 (C8a), 151.90 (C2), 171.26 (C4) ppm. IR (ATR):
ν˜ = 3048, 2953, 2656, 1687, 1626, 1579, 1506, 1455, 1358, 1308,
1258, 1078, 918, 790, 766, 700, 608 cm–1. HRMS (ESI) m/z calcd. for
C14H12N4ONa [M + Na]+ 275.0909, found 275.0909; elemental analy-
sis calcd. (%) for C14H12N4O: C 66.65, H 4.79, N 22.21; found C 66.55,
H 4.72, N 22.43.
[3-15N]-2-(1-Allyl-1H-imidazolium-3-yl)quinazolin-4-olate
(*13bd): Synthesized as described for 13bd. Yield 0.184 g, 73 %,
colorless solid, m.p. > 260 °C (dec.). 1H NMR (600 MHz, [D6]DMSO):
δ = 4.94 (d, 1J = 6.0 Hz, 2H, H6′), 5.35–5.39 (m, 2H, H8′), 6.13 (ddt,
1J = 16.4 Hz, 2J = 10.3 Hz, 3J = 6.1 Hz, 1H, H7′), 7.25 (ddd, 1J =
8.0 Hz, 2J = 7.0 Hz, 3J = 1.2 Hz, 1H, H6), 7.47 (dd, 1J = 8.2 Hz, 2J =
0.6 Hz, 1H, H8), 7.57 (ddd, 1J = 8.4 Hz, 2J = 7.0 Hz, 3J = 1.6 Hz, 1H,
H7), 7.80 (t, 1J = 1.9 Hz, 1H, H4′), 8.00 (dd, 1J = 7.9 Hz, 2J = 1.2 Hz,
1H, H5), 8.34 (t, 1J = 1.8 Hz, H5′), 9.94 (t, 1J = 1.6 Hz, 1H, H2′) ppm.
13C NMR (150 MHz, [D6]DMSO): δ = 51.19 (C6′), 119.01 (br. s, C5′),
120.34 (C8′), 122.63 (C4′), 122.84 (d, 2J = 1.6 Hz, C4a), 123.48 (C6),
125.37 (C8), 126.23 (C5), 131.67 (C7), 131.86 (C7′), 134.92 (br. s,
C2′), 150.61 (C8a), 151.95 (d, 1J = 4.4 Hz, C2), 171.28 (d, 1J = 4.0 Hz,
C4) ppm. IR (ATR): ν˜ = 3048, 2953, 2656, 1687, 1626, 1579, 1506,
1455, 1358, 1308, 1258, 1078, 918, 790, 766, 700, 608 cm–1. HRMS
(ESI) m/z calcd. for C14H1215NN3ONa [M + Na]+ 276.0879, found
276.0868.
1-Benzyl-3-(4-hydroxyquinazolin-2-yl)-1H-imidazol-3-ium
Chloride (16): A solution of 2-chloroquinazolin-4(3H)-one (360 mg,
2.0 mmol) and 2 equiv. excess of 1-benzyl-1H-imidazole (632 mg,
4.0 mmol) in 10 mL of 1,2-DCB was stirred at 100–105 °C for 2 h.
After stirring the precipitates were filtered off, washed with a small
amount of CHCl3 and dried. Yield 0.550 g, 81 %, colorless solid, m.p.
> 227 °C (dec.). 1H NMR (600 MHz, [D6]DMSO): δ = 5.64 (s, 2H,
H6′), 7.44–7.40 (m, 1H, H10′), 7.46 (t, 1J = 7.3 Hz, 2H, H9′), 7.57 (d,
1J = 7.3 Hz, 2H, H8′), 7.64 (t, 1J = 7.6 Hz, 1H, H6), 7.79 (d, 1J = 8.2 Hz,
1H, H8), 7.95 (t, 1J = 7.7 Hz, 1H, H7), 8.09 (s, 1H, H4′), 8.21 (d, 1J =
7.6 Hz, 1H, H5), 8.45 (s, 1H, H5′), 10.31 (s, 1H, H2′) ppm. 13C NMR
(151 MHz, [D6]DMSO): δ = 52.59 (C6′), 119.33 (C4a), 120.34 (C5′),
123.23 (C4′), 125.96 (C5), 126.71 (C8), 127.61 (C6), 128.68 (C8′),
128.96 (C10′), 129.02 (C9′). 134.32 (C7′), 135.44 (C7), 136.38 (C2′),
144.00 (C2), 147.84 (C8a), 165.04 (C4) ppm. 15N NMR (61 MHz,
[D6]DMSO): δ = 190.29 (N3′) ppm. IR (ATR): ν˜ = 3186, 3054, 2930,
2824, 2675, 1694, 1629, 1578, 1456, 1359, 1311, 1265, 1107, 1078,
1026, 894, 794, 764, 701, 628, 462 cm–1. HRMS (ESI) m/z calcd. for
C18H14N4ONa [M + Na]+ 325.1065, found 325.1050. Elementary anal-
ysis: calcd. for C18H15ClN4O, %: C 63.81; H 4.46; N 16.54, Cl 10.46;
found, %: 63.65; H 4.42; N 16.44, Cl 10.14.
[3-15N]-1-Benzyl-3-(4-hydroxyquinazolin-2-yl)-1H-imidazol-3-
ium Chloride (*16): Synthesized as described for 16. Yield 0.366 g,
54 %, colorless solid, m.p. > 227 °C (dec.). 1H NMR (600 MHz,
[D6]DMSO): δ = 5.63 (s, 2H, H6′), 7.49–7.39 (m, 3H, H10′, 59′), 7.57
(d, 1J = 7.1 Hz, 2H, H8′), 7.65 (t, 1J = 7.2 Hz, 1H, H6), 7.79 (d, 1J =
8.2 Hz, 1H, H8), 7.95 (t, 1J = 8.4 Hz, 1H, H7), 8.08 (s, 1H, H4′), 8.21
(dd, 1J = 8.0 Hz, 2J = 0.9 Hz, 1H, H5), 8.44 (s, 1H, H5′), 10.29 (s, 1H,
H2′) ppm. 13C NMR (600 MHz, [D6]DMSO): δ = 52.61 (C6′), 119.37
(br. s, C4a), 120.35 (C5′), 123.23 (C4′), 125.97 (C5), 126.74 (br. s, C8),
127.62 (C6), 128.68 (C8′), 128.98 (C10′), 129.04 (C9′). 134.32 (C7′),
135.45 (C7), 136.37 (C2′), 144.03 (br. s, C2), 147.89 (br. s, C8a), 165.05
(br. s, C4) ppm. IR (ATR): ν˜ = 3186, 3054, 2930, 2824, 2675, 1694,
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1629, 1578, 1456, 1359, 1311, 1265, 1107, 1078, 1026, 894, 794, 764,
701, 628, 462 cm–1. HRMS (ESI) m/z calcd. for C18H1415NN3ONa
[M + Na]+ 326.1036, found 326.1033.
General Procedure for the Formation of Thiones 17a–d and Se-
lenones 18a–d: Under an inert atmosphere a solution of 0.5 mmol
betaine and 3 equiv. excess of sulfur (48 mg, 1.5 mmol) or selenium
(118.5 mg, 1.5 mmol) in 10 mL of dry p-xylene was refluxed for
48 h. After evaporation, the resulting precipitate was purified by
column chromatography (silica gel, elution gradient petroleum
ether → petroleum ether/ethyl acetate, 2:1).
2-(3-Benzyl-2-thioxo-2,3-dihydro-1H-imidazol-1-yl)quinazolin-
4(3H)-one (17a): A sample of the betaine 13a (151 mg, 0.5 mmol)
was used. The thione 19a was obtained as solid. Yield 0.50 g, 30 %,
colorless solid, m.p. > 247 °C (dec.). 1H NMR (600 MHz, [D6]DMSO):
δ = 5.31 (s, 2H, C6′), 7.35–7.31 (m, 1H, H10′), 7.40–7.36 (m, 4H, H8′,
H9′), 7.51 (d, 1J = 2.7 Hz, 1H, H4′), 7.57–7.52 (m, 1H, H6), 7.68 (d,
1J = 8.1 Hz, 1H, H8), 7.86 (ddd, 1J = 8.4 Hz, 2J = 7.3 Hz, 3J = 1.5 Hz,
1H, H7), 7.96 (d, 1J = 2.7 Hz, 1H, H5′), 8.15 (dd, 1J = 7.9 Hz, 2J =
1.2 Hz, 1H, H5), 13.98 (s, 1H, H3) ppm. 13C NMR (151 MHz,
[D6]DMSO): δ = 49.61 (C6′), 115.64 (C5′), 119.88 (C4′), 120.72 (C4a),
126.21 (C5), 126.62 (C6),126.87 (C8), 127.82 (C9′, C10′), 128.56 (C8′),
135.01 (C7), 135.54 (C7′), 143.61 (C2), 147.47 (C8a), 160.36 (C4),
161.35 (C2′) ppm. IR (ATR): ν˜ = 3188, 3153, 3112, 3030, 2872, 2825,
1678, 1619, 1564, 1514, 1447, 1393, 1243, 1150, 797, 747, 717, 699,
659, 633, 530, 466 cm–1. HRMS (ESI) m/z calcd. for C18H15N4OS [M]+
335.0967, found 335.0967; elemental analysis calcd. (%) for
C18H14N4OS: C 64.65, H 4.22, N 16.75; found: C 64.78, H 4.16,
N 16.62.
2-(3-Methyl-2-thioxo-2,3-dihydro-1H-imidazol-1-yl)quinazolin-
4(3H)-one (17b): A sample of the betaine 13b (113 mg, 0.5 mmol)
was used. The tione 17b was obtained as brown solid. Yield 0.53 g,
41 %, m.p. > 260 °C (dec.). 1H NMR (600 MHz, [D6]DMSO): δ = 3.57
(s, 3H, H6′), 7.49 (d, 1J = 2.6 Hz, 1H, H4′), 7.56–7.52 (m, 1H, H6, H6),
7.67 (d, 1J = 8.1 Hz, 1H, H8), 7.90–7.81 (m, 1H, H6) 7.96 (d, 1J =
2.6 Hz, 1H, H5′), 8.15 (dd, 1J = 7.9 Hz, 2J = 1.1 Hz, 1H, H5), 14.13 (s,
1H, H3) ppm. 13C NMR (151 MHz, [D6]DMSO): δ = 34.47 (C6′), 114.83
(C5′), 120.75 (C4a), 120.98 (C4′), 126.30 (C5), 126.57 (C6), 126.93 (C8),
135.13 (C7), 143.64 (C2), 147.58 (C8a), 160.28 (C4), 160.95 (C2′) ppm.
IR (ATR): ν˜ = 3190, 3155, 3116, 3033, 2914, 2881, 1680, 1611, 1564,
1514, 1471, 1446, 1386, 1245, 1156, 1114, 763, 722, 699, 658,
632, 556, 511, 478 cm–1. HRMS (ESI) m/z calcd. for C12H10N4OSNa
[M + Na]+ 281.0473, found 281.0470; elemental analysis calcd. (%)
for C12H10N4OS: C 55.80, H 3.90, N 21.69; found: C 55.62, H 3.63,
N 21.45.
2-(3-Butyl-2-thioxo-2,3-dihydro-1H-imidazol-1-yl)quinazolin-
4(3H)-one (17c): A sample of the betaine 13c (134 mg, 0.5 mmol)
was used. The tione 17c was obtained as brown solid. Yield 0.108 g,
72 %, m.p. 172 °C. 1H NMR (600 MHz, [D6]DMSO): δ = 0.93 (t, 1J =
7.4 Hz, 3H, H9′), 1.38–1.28 (m, 2H, H8′), 1.77–1.69 (m, 2H, H7′), 4.05
(t, 1J = 7.3 Hz, 2H, H6′), 7.56–7.50 (m, 2H, H4′, H6), 7.67 (d, 1J =
8.1 Hz, 1H, H8), 7.86 (t, 1J = 7.6 Hz, 1H, H7), 7.96 (d, 1J = 2.6 Hz, 1H,
H5′), 8.14 (d, 1J = 7.2 Hz, 1H, H5), 14.11 (s, 1H, H3) ppm. 13C NMR
(151 MHz, [D6]DMSO): δ = 13.52 (C9′), 19.11 (C8′), 29.71 (C7′), 46.44
(C6′), 115.22 (C5′), 119.98 (C4′), 120.77 (C4a), 126.28 (C5), 126.60
(C6), 126.95 (C8), 135.09 (C7), 143.70 (C2), 147.58 (C8a), 160.32 (C4),
160.49 (C2′) ppm. IR (ATR): ν˜ = 3189, 3155, 3117, 2968, 2953, 2860,
1678, 1619, 1564, 1512, 1455, 1398, 1248, 1149, 766, 725, 703, 661,
630, 532 cm–1. HRMS (ESI) m/z calcd. for C15H16N4OSNa [M + Na]+
323.0943, found 323.0937; elemental analysis calcd. (%) for
C15H16N4OS: C 59.98, H 5.37, N 18.65; found: C 59.92, H 5.36,
N 18.49.
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2-(3-Allyl-2-thioxo-2,3-dihydro-1H-imidazol-1-yl)quinazolin-
4(3H)-one (17d): A sample of the betaine 13d (126 mg, 0.5 mmol)
was used. The tione 17d was obtained as brown solid. Yield 0.032 g,
22 %, m.p. > 155 °C (dec.). 1H NMR (600 MHz, [D6]DMSO): δ = 4.70
(d, 1J = 5.5 Hz, 2H, H6′), 5.20 (dd, 1J = 17.1 Hz, 2J = 1.4 Hz, 1H, H8′
), 5.28 (dd, 1J = 10.3 Hz, 2J = 1.3 Hz, 1H, H8′), 6.03–5.91 (m, 1H, H7′
), 7.45 (d, 1J = 2.7 Hz, 1H, H4′), 7.55 (t, 1J = 7.1 Hz, 1H, H6), 7.69 (d,
1J = 7.9 Hz, 1H, H8), 7.91–7.83 (m, 1H, H7), 7.97 (d, 1J = 2.7 Hz, 1H,
H5′), 8.16 (dd, 1J = 7.9 Hz, 2J = 1.1 Hz, 1H, H5), 14.04 (s, 1H, H3)
ppm. 13C NMR (151 MHz, [D6]DMSO): δ = 48.72 (C6′), 115.49 (C5′),
118.64 (C8′), 119.78 (C4′), 120.80 (C4a), 126.29 (C5), 126.68 (C6),
126.98 (C8), 131.46 (C7′), 135.12 (C7), 143.66 (C2), 147.56 (C8a),
160.37 (C4), 160.92 (C2′) ppm. IR (ATR): ν˜ = 3197, 3154, 3040, 2881,
2832, 1679, 1622, 1563, 1516, 1412, 1392, 1247, 1147, 767, 723,
702, 627 cm–1. HRMS (ESI) m/z calcd. for C14H12N4OSNa [M + Na]+
307.0630, found 307.0618.
2-(3-Benzyl-2-selenoxo-2,3-dihydro-1H-imidazol-1-yl)quin-
azolin-4(3H)-one (18a): A sample of the betaine 13a (151 mg,
0.5 mmol) was used. The selenone 18a was obtained as brown
solid. Yield 0.092 g, 48 %, m.p. > 232 °C (dec.). 1H NMR (600 MHz,
[D6]DMSO): δ = 5.41 (s, 2H, H6′), 7.35–7.32 (m, 1H, H10′), 7.41–7.38
(m, 2H, H9′), 7.44–7.41 (m, 2H, H8′), 7.61–7.57 (m, 1H, H6), 7.66 (d,
1J = 2.5 Hz, 1H, H4′), 7.71 (d, 1J = 7.9 Hz, 1H, H8), 7.91–7.85 (m, 1H,
H7), 8.01 (d, 1J = 2.5 Hz, 1H, H5′), 8.18 (dd, 1J = 7.9 Hz, 2J = 1.4 Hz,
1H, H5) 13.71 (s, 1H, H3) ppm. 13C NMR (151 MHz, [D6]DMSO): δ =
51.30 (C6′), 119.20 (C5′), 121.21 (C4a), 121.41 (C4′), 126.26 (C5),
127.22 (C6, C8), 127.93 (C8′, C10′), 128.60 (C9′), 135.02 (C7), 135.71
(C7′), 143.92 (C2), 147.52 (C8a), 155.30 (C2′), 161.22 (C4) ppm. 77Se
NMR (144 MHz, [D6]DMSO): δ = 100.57 ppm. IR (ATR): ν˜ = 3185,
3152, 3110, 3029, 2923, 2849, 2806, 1678, 1616, 1587, 1563, 1513,
1444, 1386, 1243, 1148, 1086, 795, 715, 701, 650, 630, 530, 461 cm–1.
HRMS (ESI) m/z calcd. for C18H14N4OSeNa [M + Na]+ 405.0231, found
405.0221.
2-(3-Methyl-2-selenoxo-2,3-dihydro-1H-imidazol-1-yl)quin-
azolin-4(3H)-one (18b): A sample of the betaine 13b (113 mg,
0.5 mmol) was used. The selenone 18b was obtained as brown
solid. Yield 0.070 g, 46 %, m.p. > 252 °C (dec.). 1H NMR (600 MHz,
[D6]DMSO): δ = 3.66 (s, 3H, H6′), 7.57 (t, 1J = 7.5 Hz, 1H, H6), 7.62
(d, 1J = 2.1 Hz, 1H, H4′), 7.70 (d, 1J = 8.1 Hz, 1H, H8), 7.87 (t, 1J =
7.6 Hz, 1H, H7), 8.06 (d, 1J = 2.1 Hz, 1H, H5′), 8.17 (d, 1J = 7.9 Hz,
1H, H5), 13.88 (s, 1H, H3) ppm. 13C NMR (151 MHz, [D6]DMSO): δ =
36.30 (C6′), 117.85 (C5′), 120.94 (C4a), 122.44 (C4′), 126.18 (C5),
126.85 (C6), 127.01 (C8), 134.95 (C7), 143.48 (C2), 147.38 (C8a),
154.31 (C2′), 160.47 (C4) ppm. 77Se NMR (114 MHz, [D6]DMSO): δ =
120.85 ppm. IR (ATR): ν˜ = 3198, 3165, 3042, 2877, 2829, 2765, 1687,
1615, 1586, 1564, 1519, 1445, 1370, 1320, 1254, 1152, 1111, 760,
729, 710, 646, 538, 468 cm–1. HRMS (ESI) m/z calcd. for C12H10N4OS-
eNa [M + Na]+ 328.9918, found 328.9909; elemental analysis calcd.
(%) for C12H10N4OSe: C 47.23, H 3.30, N 18.36; found: C 47.06,
H 3.14, N 17.96.
2-(3-Butyl-2-selenoxo-2,3-dihydro-1H-imidazol-1-yl)quinazolin-
4(3H)-one (18c): A sample of the betaine 13c (151 mg, 0.5 mmol)
was used. The selenone 18c was obtained as brown solid. Yield
0.061 g, 35 %, m.p. 171 °C. 1H NMR (600 MHz, [D6]DMSO): δ = 0.94
(t, 1J = 7.4 Hz, 3H, H9′), 1.38–1.30 (m, 2H, H8′), 1.80–1.72 (m, 2H,
H7′), 4.13 (t, 1J = 7.3 Hz, 2H, H6′), 7.61–7.56 (m, 1H, H6), 7.65 (d, 1J =
2.5 Hz, 1H, H4′), 7.71 (d, 1J = 7.7 Hz, 1H, H8), 7.88 (ddd, 1J = 8.6 Hz,
2J = 7.3 Hz, 3J = 1.5 Hz, 1H, H7), 8.03 (d, 1J = 2.5 Hz, 1H, H5′), 8.17
(dd, 1J = 7.9 Hz, 2J = 1.1 Hz, 1H, H5), 13.80 (s, 1H, H3) ppm. 13C NMR
(151 MHz, [D6]DMSO): δ = 13.55 (C9′), 19.08 (C8′), 30.04 (C7′), 48.26
(C6′), 118.55 (C5′), 121.14 (C4a), 121.49 (C4′), 126.28 (C5), 127.13
(C6), 127.21 (C8), 135.08 (C7), 143.70 (C2), 147.50 (C8a), 153.89
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(C2′), 160.81 (C4) ppm. 77Se NMR (144 MHz, [D6]DMSO): δ =
104.74 ppm. IR (ATR): ν˜ = 3184, 3154, 3115, 2949, 2926, 2860, 2811,
1679, 1617, 1586, 1564, 1512, 1455, 1393, 1320, 1249, 1086, 796,
729, 702, 651, 628, 533, 462 cm–1. HRMS (ESI) m/z calcd. for
C15H16N4OSeNa [M + Na]+ 371.0387, found 371.0404; elemental
analysis calcd. (%) for C15H16N4OSe: C 51.88, H 4.64, N 16.13; found:
C 51.97, H 4.49, N 16.06.
2-(3-Allyl-2-selenoxo-2,3-dihydro-1H-imidazol-1-yl)quinazolin-
4(3H)-one (18d): A sample of the betaine 13d (151 mg, 0.5 mmol)
was used. The selenone 18d was obtained as brown solid. Yield
0.030 g, 18 %, m.p. 174 °C. 1H NMR (600 MHz, [D6]DMSO): δ = 4.79
(dt, 1J = 5.5 Hz, 2J = 1.4 Hz, 2H, H6′), 5.22 (dd, 1J = 17.1 Hz, 2J =
1.4 Hz, 1H, H8′), 5.30 (dd, 1J = 10.3 Hz, 2J = 1.4 Hz, 1H, H8′), 6.03–
5.95 (m, 1H, H7′), 7.61–7.57 (m, 2H, H4′, H6), 7.71 (dd, 1J = 8.1 Hz,
2J = 0.5 Hz, 1H, H8), 7.91–7.86 (m, 1H, H7), 8.04 (d, 1J = 2.5 Hz, 1H,
H5′), 8.17 (dd, 1J = 7.9 Hz, 2J = 1.2 Hz, 1H, H5), 13.76 (s, 1H, H3)
ppm. 13C NMR (151 MHz, [D6]DMSO): δ = 50.56 (C6′), 118.81 (C5′),
118.83 (C8′), 121.15 (C4a), 121.30 (C4′), 126.28 (C5), 127.18 (C6, C8),
131.57(C7′), 135.08 (C7), 143.72 (C2), 147.46 (C8a), 154.61 (C2′),
160.90 (C4) ppm. 77Se NMR (144 MHz, [D6]DMSO): δ = 103.43 ppm.
IR (ATR): ν˜ = 3176, 3142, 3101, 3021, 2871, 2853, 2809, 2750, 1679,
1617, 1586, 1564, 1504, 1452, 1385, 1317, 1248, 1084, 940, 759, 735,
699, 622, 531, 464 cm–1. HRMS (ESI) m/z calcd. for C14H12N4OSeNa
[M + Na]+ 355.0074, found 355.0078.
General Procedure for the Synthesis of the Borane Adducts
with BEt3 (19a–d, 20c,d): Under an inert atmosphere a solution of
1.0 mmol of betaine and 2 equiv. excess of 1.0 M triethylborane in
hexane (2 mL) in 20 mL of dry 1,4-dioxane was stirred at 200 °C for
10 h in a bomb tube. Then, the solvent was evaporated in vacuo.
The resulting solid was purified by column chromatography (silica
gel, elution gradient for 19a–d petroleum ether → petroleum




(19a): A sample of the betaine 13a (302 mg, 1.0 mmol) was used.
The resulting solid was purified by column chromatography (silica
gel, petroleum ether/ethyl acetate, 1:1). The adduct 11a was ob-
tained as colorless solid. Yield 0.303 g, 82 %, m.p. > 244 °C (dec.).
1H NMR (600 MHz, [D6]DMSO): δ = 0.30 (t, 1J = 7.7 Hz, 6H, H2′′),
0.58 (dq, 1J = 15.1 Hz, 2J = 7.6 Hz, 2H, H1′′), 1.04 (dq, 1J = 15.3 Hz,
1J = 7.7 Hz, 2H, H1′′), 5.41 (s, 2H, H6′), 7.37–7.34 (m, 2H, H9′), 7.40–
7.36 (m, 1H, H10′), 7.43 (m, 2H, H8′), 7.46 (t, 1J = 7.5 Hz, 1H, H6),
7.63 (d, 1J = 7.9 Hz, 1H, H8), 7.76 (t, 1J = 7.6 Hz, 1H, H7), 7.89 (d,
1J = 2.0 Hz, 1H, H4′), 8.12 (dd, 1J = 7.9 Hz, 2J = 1.2 Hz, 1H, H5), 8.24
(d, 1J = 2.0 Hz, 1H, H5′) ppm. 13C NMR (151 MHz, [D6]DMSO): δ =
10.41 (C2′′), 11.08 (br. s, C1′′), 51.76 (C6′), 114.03 (C5′), 121.62 (C4a),
125.65 (C6), 125.99 (C8), 126.30 (C5), 126.64 (C4′), 127.66 (C8′),
128.44 (C10′), 128.86(C9′), 133.65 (C7), 135.23 (C7′), 148.02 (C2),
148.12 (C8a), 162.92 (C4), 172.69 (br. s, C2′) ppm. 11B NMR (193 MHz,
[D6]DMSO): δ = –0.68 ppm. IR (ATR): ν˜ = 3135, 2939, 2860, 2818,
1662, 1628, 1606, 1560, 1466, 1411, 1339, 1192, 1130, 1048, 1023,
940, 874, 764, 736, 713, 682 cm–1. HRMS (ESI) m/z calcd. for
C22H23BN4ONa [M + Na]+ 393.1863, found 393.1858; elemental anal-
ysis calcd. (%) for C22H23BN4O: C 71.37, H 6.26, N 15.13; found: C
71.24, H 6.31, N 15.06.
1-Methyl-12,12-diethyl-10-oxo-10,12-dihydro-1H-imidazo-
[2′,1′:3,4][1,4,2]diazaborolo[5,1-b]quinazolin-4-ium-12-ide
(19b): A sample of the betaine 13b (226 mg, 1.0 mmol) was used.
The resulting solid was purified by column chromatography (silica
gel, petroleum ether/ethyl acetate, 1:1). The adduct 19b was ob-
tained as colorless solid. Yield 0.118 g, 40 %, m.p. 207 °C. 1H NMR
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(600 MHz, [D6]DMSO): δ = 0.41 (t, 1J = 7.7 Hz, 6H, H2′′), 0.68 (dq,
1J = 15.2 Hz, 2J = 7.7 Hz, 2H, H1′′), 1.02 (dq, 1J = 15.4 Hz, 2J = 7.7 Hz,
2H, H1′′), 3.86 (s, 3H, H6′), 7.45 (ddd, 1J = 8.1 Hz, 2J = 7.1 Hz, 3J =
1.1 Hz, 1H, H6), 7.62 (dd, 1J = 8.1 Hz, 2J = 0.6 Hz, 1H, H8), 7.76 (ddd,
1J = 8.6 Hz, 2J = 7.1 Hz, 3J = 1.6 Hz, 1H, H7), 7.79 (d, 1J = 2.0 Hz, 1H,
H4′), 8.12 (dd, 1J = 7.9 Hz, 2J = 1.2 Hz, 1H, H5), 8.16 (d, J = 2.0 Hz,
1H, H5′) ppm. 13C NMR (151 MHz, [D6][D6]DMSO): δ = 10.63 (C2′′),
10.72 (br. s, C1′′), 35.27 (C6′), 113.44 (C5′), 121.62 (C4a), 125.59 (C6),
125.96 (C8), 126.30 (C5), 127.53 (C4′), 133.63 (C7), 148.04 (C2),
148.17 (C8a), 163.00 (C4), 172.43 (br. s, C2′) ppm. 11B NMR (193 MHz,
[D6]DMSO): δ = –0.79 ppm. IR (ATR): ν˜ = 3173, 2941, 2863, 2813,
1651, 1634, 1608, 1561, 1465, 1408, 1343, 1232, 1205, 1128, 942,
876, 777, 723, 679 cm–1. HRMS (ESI) m/z calcd. for C16H19BN4ONa
[M + Na]+ 317.1550, found 317.1540; elemental analysis calcd. (%)




(19c): A sample of the betaine 13c (268 mg, 1.0 mmol) was used.
The resulting solid was purified by column chromatography (silica
gel, petroleum ether/ethyl acetate, 1:1). The adduct 19c was ob-
tained as colorless solid. Yield 0.135 g, 40 %, m.p. 115 °C. 1H NMR
(600 MHz, [D6]DMSO): δ = 0.37 (t, 1J = 7.7 Hz, 6H, H2′′), 0.62 (dq,
1J = 15.0 Hz, 1J = 7.6 Hz, 2H, H1′′), 0.93 (t, 1J = 7.4 Hz, 3H, H9′), 1.08
(dq, 1J = 15.3, 2J = 7.7 Hz, 2H, H1′′), 1.39–1.32 (m, 2H, H8′), 1.88–
1.78 (m, 2H, H7′), 4.13 (t, 1J = 7.4 Hz, 2H, H6′), 7.45 (t, 1J = 7.5 Hz,
1H, H6), 7.62 (d, 1J = 8.0 Hz, 1H, H8), 7.76 (t, 1J = 7.6 Hz, 1H, H7),
7.91 (d, 1J = 1.9 Hz, 1H, H4′), 8.12 (dd, 1J = 7.9 Hz, 2J = 1.1 Hz, 1H,
H5), 8.20 (d, 1J = 1.9 Hz, 1H, H5 ′) ppm. 13C NMR (151 MHz,
[D6]DMSO): δ = 10.43 (C2′′), 11.21 (br. s, C1′′), 13.43 (C9′), 19.03 (C8′
), 31.79 (C7′), 48.22 (C6′), 113.79 (C5′), 121.60 (C4a), 125.61 (C6),
125.96 (C8), 126.07 (C4′), 126.31 (C5), 133.65 (C7), 148.05 (C2),
148.16 (C8a), 162.95 (C4), 171.97 (br. s, C2′) ppm. 11B NMR (193 MHz,
[D6]DMSO): δ = –0.64 ppm. IR (ATR): ν˜ = 3103, 3078, 2939, 2865,
2822, 1660, 1631, 1608, 1558, 1472, 1429, 1416, 1343, 1133, 1024,
944 , 796 , 766 , 687 , 543 cm–1 . HRMS (ES I ) m /z ca lcd. for
C19H25BN4ONa [M + Na]+ 359.2019, found 359.2014; elemental anal-
ysis calcd. (%) for C19H25BN4O: C 67.87, H 7.49, N 16.66; found:
C 68.07, H 7.45, N 16.61.
1-Allyl-12,12-diethyl-10-oxo-10,12-dihydro-1H-imidazo-
[2′,1′:3,4][1,4,2]diazaborolo[5,1-b]quinazolin-4-ium-12-ide
(19d): A sample of the betaine 13d (252 mg, 1.0 mmol) was used.
The resulting solid was purified by column chromatography (silica
gel, petroleum ether/ethyl acetate, 1:1). The adduct 19d was ob-
tained as colorless solid. Yield 0.100 g, 31 %, m.p. 141 °C. 1H NMR
(600 MHz, [D6]DMSO): δ = 0.37 (t, 1J = 7.7 Hz, 6H, H2′′) 0.63 (dq,
1J = 15.2 Hz, 2J = 7.7 Hz, 2H, H1′′), 1.04 (dq, 1J = 15.3 Hz, 2J = 7.7 Hz,
2H, H1′′), 4.81 (d, 1J = 5.7 Hz, 2H, H6′), 5.26 (dd, 1J = 17.1 Hz, 2J =
1.1 Hz, 1H, H8′), 5.35 (dd, 1J = 10.3 Hz, 1J = 1.0 Hz, 1H, H8′), 6.07
(dq, 1J = 10.7 Hz, 2J = 5.7 Hz, 1H, H7′), 7.46 (t, 1J = 7.5 Hz, 1H, H6),
7.63 (d, 1J = 7.9 Hz, 1H, H8), 7.76 (t, 1J = 7.2 Hz, 1H, H7), 7.82 (d,
1J = 2.0 Hz, 1H, H4′), 8.12 (dd, 1J = 7.9 Hz, 2J = 1.3 Hz, 1H, H5), 8.22
(d, 1J = 2.0 Hz, 1H, H5′) ppm. 13C NMR (151 MHz, [D6]DMSO): δ =
10.47 (C2′′), 11.06 (br. s, C1′′), 50.55 (C6′), 113.94 (C5′), 119.13 (C8′),
121.63 (C4a), 125.67 (C6), 126.00 (C8), 126.33 (C4′), 126.39 (C5),
132.28 (C7′), 133.69 (C7), 148.04 (C2), 148.16 (C8a), 162.99 (C4),
172.51 (br. s, C2 ′) ppm. 11B NMR (193 MHz, [D6]DMSO): δ =
–1.01 ppm. IR (ATR): ν˜ = 3129, 2931, 2861, 2814, 1632, 1604, 1559,
1469, 1412, 1335, 1194, 1127, 1048, 1023, 913, 873, 768, 738, 683,
545 cm–1. HRMS (ESI) m/z calcd. for C18H21BN4ONa [M + Na]+
343.1706, found 343.1696; elemental analysis calcd. (%) for





(20c): A sample of the betaine 13c (268 mg, 1.0 mmol) was used.
The resulting solid was purified by column chromatography (silica
gel, ethyl acetate/MeOH, 10:1). The adduct 20c was obtained as
colorless solid. Yield 0.037 g, 11 %, m.p. 172 °C. 1H NMR (600 MHz,
[D6]DMSO): δ = 0.31 (t, 1J = 7.7 Hz, 6H, H2′′), 0.86–0.79 (m, 2H, H1′′),
1.01–0.92 (m, 5H, H1′′, H9′), 1.40–1.33 (m, 2H, H8′), 1.88–1.81 (m,
2H, H7′), 4.18 (t, 1J = 7.4 Hz, 2H, H6′), 7.42 (t, 1J = 7.4 Hz, 1H, H6),
7.65 (d, 1J = 8.3 Hz, 1H, H8), 7.75 (t, 1J = 7.7 Hz, 1H, H7), 7.92 (d,
1J = 2.0 Hz, 1H, H4′), 8.12 (dd, 1J = 7.9 Hz, 2J = 1.3 Hz, 1H, H5), 8.20
(d, 1J = 2.0 Hz, 1H, H5′) ppm. 13C NMR (151 MHz, [D6]DMSO): δ =
10.05 (C2′′), 12.87 (br. s, C1′′), 13.48 (C9′), 19.03 (C8′), 31.83 (C7′),
48.31 (C6′), 114.11 (C5′), 117.94 (C8), 119.81 (C4a), 124.60 (C6),
125.91 (C4′), 127.64 (C5), 133.62 (C7), 142.39 (C8a), 151.54 (C2),
169.58 (C4), 171.18 (br. s, C2′) ppm. 11B NMR (193 MHz, [D6]DMSO):
δ = 0.19 ppm. IR (ATR): ν˜ = 3098, 2935, 2860, 2821, 1645, 1598, 1542,
1479, 1443, 1415, 1377, 1330, 1123, 1016, 881, 763, 695, 532 cm–1.
HRMS (ESI) m/z calcd. for C19H25BN4ONa [M + Na]+ 359.2019, found
359.2016; elemental analysis calcd. (%) for C19H25BN4O: C 67.87,
H 7.49, N 16.66; found: C 67.82, H 7.31, N 16.85.
10-Allyl-11,11-diethyl-5-oxo-10,11-dihydro-5H-imidazo-
[2′,1′:3,4][1,4,2]diazaborolo[1,5-a]quinazolin-7-ium-11-ide
(20d): A sample of the betaine 13d (252 mg, 1.0 mmol) was used.
The resulting solid was purified by column chromatography (silica
gel, ethyl acetate/MeOH, 10:1). The Adduct 20d was obtained as
colorless solid. Yield 0.032 g, 10 %, m.p. 141 °C. 1H NMR (600 MHz,
[D6]DMSO): δ = 0.30 (t, 1J = 7.7 Hz, 6H, H2′′), 0.87–0.80 (m, 2H, H1′′),
0.97–0.90 (m, 2H, H1′′), 4.86 (dt, 1J = 5.6 Hz, 2J = 1.4 Hz, 2H, H6′),
5.27 (dq, 1J = 17.1 Hz, 2J = 1.5 Hz, 1H, H8′), 5.36 (dq, 1J = 10.3 Hz,
2J = 1.2 Hz, 1H, H8′), 6.09 (ddt, 1J = 17.1 Hz, 2J = 10.4 Hz, 3J = 5.6 Hz,
1H, H7′), 7.42 (ddd, 1J = 8.0 Hz, 2J = 7.2 Hz, 3J = 1.0 Hz, 1H, H6),
7.64 (d, 1J = 8.1 Hz, 1H, H8), 7.75 (ddd, 1J = 8.6 Hz, 2J = 7.1 Hz, 3J =
1.6 Hz, 1H, H7),7.83 (d, 1J = 2.0 Hz, 1H, H4′), 8.12 (dd, 1J = 7.9 Hz,
1J = 1.5 Hz, 1H, H5), 8.21 (d, 1J = 2.0 Hz, 1H, H5′) ppm. 13C NMR
(151 MHz, [D6]DMSO): δ = 10.09 (C2′′), 10.12 (br. s, C1′′), 50.61
(C6′), 114.21 (C5′), 117.98 (C8), 119.07 (C8′), 119.82 (C4a), 124.64
(C7), 126.32 (C4′), 127.65 (C5), 132.30 (C7′), 133.65 (C7), 142.41 (C8a),
151.54 (C2), 169.59 (C4), 171.60 (br. s, C2′) ppm. 11B NMR (193 MHz,
[D6]DMSO): δ = 0.76 ppm. IR (ATR): ν˜ = 3116, 2941, 2863, 2820,
1647, 1596, 1540, 1479, 1445, 1412, 1378, 1328, 1122, 1047, 915,
878, 765, 696, 540 cm–1. HRMS (ESI) m/z calcd. for C18H21BN4ONa
[M + Na]+ 343.1706, found 343.1701; elemental analysis calcd. (%)
for C18H21BN4O: C 67.52, H 6.61, N 17.50; found: C 67.64, H 6.46,
N 17.71.
General Procedure for the Synthesis of the Borane Adducts
with BPh3 (21a–d, 22c,d): Under an inert atmosphere a solution
of 1.0 mmol of betaine and 2 equiv. excess of 0.25 M triphenylbo-
rane in THF (8 mL) in 20 mL of dry 1,4-dioxane was stirred at 200 °C
for 20 h in a bomb tube. Then, the solvent was evaporated in vacuo.
The resulting solid was purified by column chromatography (silica
gel, elution gradient for 21a–d petroleum ether → petroleum




(21a): A sample of the betaine 13a (302 mg, 1.0 mmol) was used.
The resulting solid was purified by column chromatography (silica
gel, petroleum ether/ethyl acetate, 1:1). The adduct 21a was ob-
tained as colorless solid. Yield 0.326 g, 70 %, m.p. > 268 °C (dec.).
1H NMR (600 MHz, [D6]DMSO): δ = 5.16 (s, 2H, H6′), 6.69 (d, 1J =
7.5 Hz, 2H, H8′), 7.14 (ddd, 1J = 13.8 Hz, 2J = 5.4 Hz, 3J = 1.7 Hz, 2H,
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H9′), 7.20–7.15 (m, 6H, H3′′, H4′′), 7.22 (t, 1J = 7.5 Hz, 1H, H10′),
7.35–7.30 (m, 4H, H2′′), 7.46 (ddd, 1J = 8.1 Hz, 2J = 7.2 Hz, 3J =
1.1 Hz, 1H, H6), 7.68 (d, 1J = 8.1 Hz, 1H, H8), 7.74 (d, 1J = 2.1 Hz, 1H,
H4′), 7.78 (t, 1J = 7.6 Hz, 1H, H7), 8.05 (d, 1J = 7.9 Hz, 1H, H5), 8.32
(d, 1J = 2.1 Hz, 1H, H5′) ppm. 13C NMR (151 MHz, [D6]DMSO): δ =
51.72 (C6′), 114.90 (C5′), 122.03 (C4a), 126.08 (C6), 126.15 (C4′′),
126.20 (C8), 126.29 (C4′), 126.44 (C5), 127.35 (C3′′), 128.17 (C8′),
128.41 (C10′), 128.57 (C9′), 133.73 (C2′′), 133.98 (C7), 134.06 (C7′),
143.88 (C1′′), 147.62 (C2), 147.70 (C8a), 162.27 (C4), 169.11 (C2′)
ppm. 11B NMR (193 MHz, [D6]DMSO): δ = –2.50 ppm. IR (ATR): ν˜ =
3147, 3087, 3002, 1671, 1640, 1609, 1556, 1468, 1415, 1359, 1189,
1118, 949, 876, 765, 694, 638 cm–1. HRMS (ESI) m/z calcd. for
C30H23BN4ONa [M + Na]+ 489.1863, found 489.1859; elemental anal-
ysis calcd. (%) for C30H23BN4O: C 77.27, H 4.97, N 12.01; found:
C 77.18, H 5.00, N 11.86.
[3-15N]-1-Benzyl-10-oxo-12,12-diphenyl-10,12-dihydro-1H-
imidazo[2′,1′:3,4][1,4,2]diazaborolo[5,1-b]quinazolin-4-ium-12-
ide (*21a): Synthesized as described for 21a. Yield 0.336 g, 72 %,
colorless solid, m.p. > 268 °C (dec.). 1H NMR (600 MHz, [D6]DMSO):
δ = 5.16 (s, 2H, H6′), 6.69 (d, 1J = 7.5 Hz, 2H, H8′), 7.14 (ddd, 1J =
13.8 Hz, 2J = 5.4 Hz, 3J = 1.7 Hz, 2H, H9′), 7.20–7.15 (m, 6H, H3′′,
H4′′), 7.22 (t, 1J = 7.5 Hz, 1H, H10′), 7.35–7.30 (m, 4H, H2′′), 7.46
(ddd, 1J = 8.1 Hz, 2J = 7.2 Hz, 3J = 1.1 Hz, 1H, H6), 7.68 (d, 1J =
8.1 Hz, 1H, H8), 7.74 (d, 1J = 2.1 Hz, 1H, H4′), 7.78 (t, 1J = 7.6 Hz, 1H,
H7), 8.05 (d, 1J = 7.9 Hz, 1H, H5), 8.32 (d, 1J = 2.1 Hz, 1H, H5′ ) ppm.
13C NMR (151 MHz, [D6]DMSO): δ = 51.72 (C6′), 114.91 (C5′), 122.03
(d, 2J = 5.1 Hz, C4a), 126.08 (C6), 126.15 (C4′′), 126.20 (C8), 126.29
(C4′), 126.44 (C5), 127.35 (C3′′), 128.17 (C8′), 128.41 (C10′), 128.57
(C9′), 133.73 (C2′′), 133.98 (C7), 134.06 (C7′), 143.88 (C1′′), 147.61 (d,
1J = 11.9 Hz, C2), 147.70 (C8a), 162.26 (d, 1J = 11.1 Hz, C4), 168.99
(C2′) ppm. 11B NMR (193 MHz, [D6]DMSO): δ = –2.50 ppm. IR (ATR):
ν˜ = 3147, 3087, 3002, 1671, 1640, 1609, 1556, 1468, 1415, 1359,
1189, 1118, 949, 876, 765, 694, 638 cm–1. HRMS (ESI) m/z calcd. for
C30H23B15NN3ONa [M + Na]+ 490.1833, found 490.1829.
1-Methyl-10-oxo-12,12-diphenyl-10,12-dihydro-1H-imidazo-
[2′,1′:3,4][1,4,2]diazaborolo[5,1-b]quinazolin-4-ium-12-ide
(21b): A sample of the betaine 13b (226 mg, 1.0 mmol) was used.
The resulting solid was purified by column chromatography (silica
gel, petroleum ether/ethyl acetate, 1:1). The adduct 21b was ob-
tained as colorless solid. Yield 0.125 g, 32 %, m.p. > 303 °C (dec.).
1H NMR (600 MHz, [D6]DMSO): δ = 3.65 (s, 3H, H6′), 7.16–7.13 (m,
2H, H4′′), 7.20–7.16 (m, 4H, H3′′), 7.26 (dd, 1J = 8.1 Hz, 2J = 1.4 Hz,
4H, H2′′), 7.46 (t, 1J = 8.0 Hz, 1H, H6), 7.68 (d, 1J = 7.6 Hz, 1H, H8),
7.78 (ddd, 1J = 8.5 Hz, 2J = 7.2 Hz, 3J = 1.6 Hz, 1H, H7), 7.82 (d, 1J =
2.0 Hz, 1H, H4′), 8.05 (dd, 1J = 7.9 Hz, 1J = 1.3 Hz, 1H, H5), 8.30 (d,
1J = 2.0 Hz, 1H, H5′) ppm. 13C NMR (151 MHz, [D6]DMSO): δ = 35.50
(C6′), 113.93 (C5′), 122.00 (C4a), 126.02 (C4′′), 126.03 (C6), 126.16
(C8), 126.43 (C5), 127.18 (C3′′), 128.13 (C4′), 133.67 (C2′′), 133.97
(C7), 143.75 (C1′′), 147.66 (C2), 147.69 (C8a), 162.33 (C4), 168.94
(C2′) ppm. 11B NMR (193 MHz, [D6]DMSO): δ = –2.53 ppm. IR (ATR):
ν˜ = 3185, 3109, 3004, 1665, 1641, 1608, 1563, 1468, 1410, 1336,
1127, 875, 765, 700, 648 cm–1. HRMS (ESI) m/z calcd. for C24H20BN4O
[M]+ 391.1730, found 391.1729; elemental analysis calcd. (%) for




ide (*21b): Synthesized as described for 21b. Yield 0.137 g, 35 %,
colorless solid, m.p. > 303 °C (dec.). 1H NMR (600 MHz, [D6]DMSO):
δ = 3.65 (s, 3H, H6′), 7.16–7.13 (m, 2H, H4′′), 7.20–7.16 (m, 4H,
H3′′), 7.26 (dd, 1J = 8.1 Hz, 2J = 1.4 Hz, 4H, H2′′), 7.46 (t, 1J = 8.0 Hz,
1H, H6), 7.68 (d, 1J = 7.8 Hz, 1H, H8), 7.78 (ddd, 1J = 8.5 Hz, 2J =
Communication
7.2 Hz, 3J = 1.6 Hz, 1H, H7), 7.81 (d, 1J = 2.0 Hz, 1H, H4′), 8.04 (dd,
1J = 7.9 Hz, 1J = 1.2 Hz, 1H, H5), 8.29 (d, 1J = 2.0 Hz, 1H, H5′) ppm.
13C NMR (151 MHz, [D6]DMSO): δ = 35.52 (C6′), 113.96 (C5′), 122.01
(d, 2J = 5.2 Hz, C4a), 126.05 (C4′′), 126.08 (C6), 126.18 (C8), 126.46
(C5), 127.22 (C3′′), 128.15 (C4′), 133.69 (C2′′), 134.01 (C7), 143.77
(C1′′), 147.67 (d, 1J = 11.7 Hz, C2), 147.71 (C8a), 162.36 (d, 1J =
11.1 Hz, C4), 168.97 (C2′) ppm. 11B NMR (193 MHz, [D6]DMSO): δ =
–2.49 ppm. IR (ATR): ν˜ = 3185, 3109, 3004, 1665, 1641, 1608, 1563,
1468, 1410, 1336, 1127, 875, 765, 700, 648 cm–1. HRMS (ESI) m/z
calcd. for C24H19B15NN3ONa [M + Na]+ 414.1520, found 414.1510.
1-Butyl-10-oxo-12,12-diphenyl-10,12-dihydro-1H-imidazo-
[2′,1′:3,4][1,4,2]diazaborolo[5,1-b]quinazolin-4-ium-12-ide
(21c): A sample of the betaine 13c (268 mg, 1.0 mmol) was used.
The resulting solid was purified by column chromatography (silica
gel, petroleum ether/ethyl acetate, 1:1). The adduct 21c was ob-
tained as colorless solid. Yield 0.030 g, 7 %, m.p. > 244 °C (dec.). 1H
NMR (600 MHz, [D6]DMSO): δ = 0.60 (t, 1J = 7.4 Hz, 3H, H9′), 0.96–
0.88 (m, 2H, H8′), 1.31–1.24 (m, 2H, H7′), 3.93 (t, 1J = 7.6 Hz, 2H,
H6′), 7.21–7.13 (m, 6H, H3′′, H4′′), 7.28–7.26 (m, 4H, H2′′), 7.45 (t,
1J = 7.5 Hz, 1H, H6), 7.68 (d, 1J = 8.0 Hz, 1H, H8), 7.78 (t, 1J = 7.6 Hz,
1H, H7), 0.60 (t, 1J = 7.4 Hz, 1H, H4′), 8.03 (dd, 1J = 7.9 Hz, 2J =
1.0 Hz, 1H, H5), 8.34 (d, 1J = 1.9 Hz, 1H, H5 ′) ppm. 13C NMR
(151 MHz, [D6]DMSO): δ = 13.22 (C9′), 18.61 (C8′), 30.93 (C7′), 48.44
(C6′), 114.31 (C5′), 121.99 (C4a), 126.03 (C6), 126.06 (C4′′), 126.17
(C8), 126.41 (C5), 126.56 (C4′), 127.20 (C3′′), 133.61 (C2′′), 133.96
(C7), 143.89 (C1′′), 147.67 (C2), 147.73 (C8a), 162.22 (C4), 168.82
(C2′) ppm. 11B NMR (193 MHz, [D6]DMSO): δ = –2.41 ppm. IR (ATR):
ν˜ = 3211, 3156, 3116, 2934, 2867, 1728, 1668, 1637, 1556, 1487,
1469, 1431, 1328, 1234, 1108, 946, 874, 767, 704, 656 cm–1. HRMS
(ESI) m/z calcd. for C27H25BN4ONa [M + Na]+ 455.2019, found
455.2021; elemental analysis calcd. (%) for C27H25BN4O: C 75.01,
H 5.83, N 12.96; found: C 74.94, H 5.77, N 12.82.
1-Allyl-10-oxo-12,12-diphenyl-10,12-dihydro-1H-imidazo-
[2′,1′:3,4][1,4,2]diazaborolo[5,1-b]quinazolin-4-ium-12-ide
(21d): A sample of the betaine 13d (252 mg, 1.0 mmol) was used.
The resulting solid was purified by column chromatography (silica
gel, petroleum ether/ethyl acetate, 1:1). The adduct 22d was ob-
tained as colorless solid. Yield 0.100 g, 24 %, m.p. > 278 °C (dec.).
1H-NMR (600 MHz, [D6]DMSO): δ = 4.59 (d, 1J = 6.1 Hz, 2H, H6′),
4.98 (dd, 1J = 17.1 Hz, 2J = 1.2 Hz, 1H, H8′), 5.08 (dd, 1J = 10.3 Hz,
2J = 1.0 Hz, 1H, H8′), 5.58 (ddt, 1J = 16.3 Hz, 2J = 10.3 Hz, 3J = 6.1 Hz,
1H, H7′), 7.22–7.11 (m, 6H, H3′′, H4′′), 7.27 (dd, 1J = 7.8 Hz, 2J =
1.6 Hz, 4H, H2′′), 7.46 (t, 1J = 7.5 Hz, 1H, H6), 7.69 (d, 1J = 7.6 Hz,
1H, H8), 7.79 (ddd, 1J = 8.5 Hz, 2J = 7.2 Hz, 3J = 1.5 Hz, 1H, H7), 7.85
(d, 1J = 2.1 Hz, 1H, H4′), 8.04 (dd, 1J = 7.9 Hz, 2J = 1.2 Hz, 1H, H5),
8.36 (d, 1J = 2.0 Hz, 1H, H5′) ppm. 13C NMR (151 MHz, [D6]DMSO):
δ = 50.52 (C6′), 114.63 (C5′), 120.27 (C8′), 122.00 (C4a), 126.07 (C6,
C4′′), 126.18 (C8), 126.43 (C5), 126.49 (C4′), 127.18 (C2′′), 130.75
(C7′), 133.70 (C3′′), 133.98 (C7), 143.78 (C1′′), 147.62 (C2), 147.69
(C8a), 162.25 (C4), 169.05 (C2′) ppm. 11B NMR (193 MHz, [D6]DMSO):
δ = –2.62 ppm. IR (ATR): ν˜ = 3156, 3087, 3000, 1667, 1636, 1609,
1554, 1486, 1432, 1337, 1128, 944, 875, 768, 749, 708, 639 cm–1.
HRMS (ESI) m/z calcd. for C26H21BN4ONa [M + Na]+ 439.1706, found
439.1697; elemental analysis calcd. (%) for C26H21BN4O: C 75.02,
H 5.08, N 13.46; found: C 74.99, H 5.06, N 13.29.
[3-15N]-1-Allyl-10-oxo-12,12-diphenyl-10,12-dihydro-1H-imid-
azo[2′,1′:3,4][1,4,2]diazaborolo[5,1-b]quinazolin-4-ium-12-ide
(*21d): Synthesized as described for 21d. Yield 0.112 g, 27 %; color-
less solid, m.p. > 278 °C (dec.). 1H-NMR ([D6]DMSO, 600 MHz): δ =
4.59 (d, 1J = 6.1 Hz, 2H, H6′), 4.98 (dd, 1J = 17.1 Hz, 2J = 1.2 Hz, 1H,
H8′), 5.07 (dd, 1J = 10.3 Hz, 2J = 1.0 Hz, 1H, H8′), 5.58 (ddt, 1J =
16.3 Hz, 2J = 10.3 Hz, 3J = 6.1 Hz, 1H, H7′), 7.22–7.11 (m, 6H, H3′′,
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H4′′), 7.27 (dd, 1J = 7.8 Hz, 2J = 1.6 Hz, 4H, H2′′), 7.46 (t, 1J = 7.5 Hz,
1H, H6), 7.69 (d, 1J = 7.6 Hz, 1H, H8), 7.79 (ddd, 1J = 8.5 Hz, 2J =
7.2 Hz, 3J = 1.5 Hz, 1H, H7), 7.85 (d, 1J = 2.1 Hz, 1H, H4′), 8.03 (dd,
1J = 7.9 Hz, 2J = 1.2 Hz, 1H, H5), 8.36 (d, 1J = 2.0 Hz, 1H, H5′) ppm.
13C-NMR (151 MHz, [D6]DMSO): δ = 50.53 (C6′), 114.65 (C5′), 120.30
(C8′), 122.01 (d, 2J = 4.7 Hz, C4a), 126.10 (C6, C4′′), 126.20 (C8),
126.44 (C5), 126.51 (C4′), 127.20 (C2′′), 130.77 (C7′), 133.71 (C3′′),
134.01 (C7), 143.78 (C1′′), 147.63 (d, 1J = 11.6 Hz, C2), 147.70 (C8a),
162.26 (d, 1J = 11.1 Hz, C4), 169.05 (C2′) ppm. 11B-NMR ([D6]DMSO,
193 MHz): δ = –1.80 ppm. IR (ATR): ν˜ = 3156, 3087, 3000, 1667,
1636, 1609, 1554, 1486, 1432, 1337, 1128, 944, 875, 768, 749, 708,




(22c): A sample of the betaine 13c (268 mg, 1.0 mmol) was used.
The resulting solid was purified by column chromatography (silica
gel, ethyl acetate/MeOH, 10:1). The adduct 22c was obtained as
colorless solid. Yield 0.065 g, 15 %, m.p. > 268 °C (dec.). 1H NMR
(600 MHz, [D6]DMSO): δ = 0.62 (t, 1J = 7.4 Hz, 3H, H9′), 1.03–0.96
(m, 2H, H8′), 1.39–1.32 (m, 2H, H7′), 3.93 (t, 1J = 7.4 Hz, 2H, H6′),
7.12 (d, 1J = 8.3 Hz, 1H, H8), 7.20 (t, 1J = 7.2 Hz, 2H, H4′′), 7.25 (t,
1J = 7.3 Hz, 4H, H3′′), 7.32–7.28 (m, 5H, H6, H2′′), 7.45 (t, 1J = 7.4 Hz,
1H, H7), 7.87 (d, 1J = 2.0 Hz, 1H, H4′), 8.08 (dd, 1J = 7.9 Hz, 2J =
1.2 Hz, 1H, H5), 8.29 (d, 1J = 2.0 Hz, 1H, H5 ′) ppm. 13C NMR
(151 MHz, [D6]DMSO): δ = 13.07 (C9′), 18.56 (C8′), 30.82 (C7′), 48.38
(C6′), 114.29 (C5′), 119.35 (C8), 119.91 (C4a), 124.55 (C6), 126.42
(C4′), 126.68 (C4′′), 127.39 (C5), 127.86 (C3′′), 132.88 (C7), 133.39
(C2′′), 141.69 (C8a), 142.27 (C1′′), 151.53 (C2), 168.65 (C2′), 169.40
(C4) ppm. 11B NMR (193 MHz, [D6]DMSO): δ = –2.05 ppm. IR (ATR):
ν˜ = 3163, 3144, 3065, 2938, 1662, 1600, 1544, 1473, 1448, 1416,
1375, 1180, 1121, 1021, 979, 869, 793, 758, 711, 662, 596, 537 cm–1.
HRMS (ESI) m/z calcd. for C27H25BN4ONa [M + Na]+ 455.2019, found
455.2015; elemental analysis calcd. (%) for C27H25BN4O: C 75.01,
H 5.83, N 12.96; found: C 74.92, H 5.86, N 12.82.
10-Allyl-5-oxo-11,11-diphenyl-10,11-dihydro-5H-imidazo-
[2′,1′:3,4][1,4,2]diazaborolo[1,5-a]quinazolin-7-ium-11-ide
(22d): A sample of the betaine 13d (252 mg, 1.0 mmol) was used.
The resulting solid was purified by column chromatography (silica
gel, ethyl acetate/MeOH, 10:1). The adduct 22d was obtained as
colorless solid. Yield 0.080 g, 19 %, m.p. > 285 °C (dec.). 1H NMR
(600 MHz, [D6]DMSO): δ = 4.59 (d, 1J = 6.0 Hz, 2H, H6′), 4.98 (dd,
1J = 17.1, 2J = 1.1 Hz, 1H, H8′), 5.06 (dd, 1J = 10.3, 2J = 1.0 Hz, 1H,
H8′), 5.63–5.56 (m, 1H, H7′), 7.13 (d, 1J = 8.3 Hz, 1H, H8), 7.21–7.17
(m, 2H, H4′′), 7.24 (t, 1J = 7.3 Hz, 4H, H3′′), 7.31–7.28 (m, 2H), 7.32–
7.28 (m, 5H, H2′′, H6), 7.45 (ddd, 1J = 8.6 Hz, 2J = 7.2 Hz, 3J = 1.6 Hz,
1H, H7), 7.79 (d, 1J = 2.0 Hz, 1H, H4′), 8.09 (dd, 1J = 7.9 Hz, 1J =
1.4 Hz, 1H, H8), 8.31 (d, 1J = 2.0 Hz, 1H, H5 ′) ppm. 13C NMR
(151 MHz, [D6]DMSO): δ = 50.55 (C6′), 114.72 (C5′), 119.40 (C8),
119.94 (C4a), 120.15 (C8′′), 124.69 (C6), 126.35 (C4′), 126.77 (C4′′),
127.47 (C5), 127.92 (C3′′), 130.70 (C7′), 133.00 (C7), 133.59 (C2′′),
141.80 (C8a), 142.23 (C1′′), 151.57 (C2), 169.05 (C2′), 169.49 (C4)
ppm. 11B NMR (193 MHz, [D6]DMSO): δ = –2.19 ppm. IR (ATR): ν˜ =
3158, 3139, 3003, 1642, 1601, 1541, 1479, 1409, 1329, 1271, 1181,
984 , 874 , 768 , 708 , 632 cm–1 . HRMS (ES I ) m /z ca lcd. for
C26H21BN4ONa [M + Na]+ 439.1706, found 439.1700; elemental anal-
ysis calcd. (%) for C26H21BN4O: C 75.02, H 5.08, N 13.46; found:
C 75.20, H 5.10, N 13.30.
[3-15N]-10-Allyl-5-oxo-11,11-diphenyl-10,11-dihydro-5H-imid-
azo[2′,1′:3,4][1,4,2]diazaborolo[1,5-a]quinazolin-7-ium-11-ide
(*22d): Synthesized as described for 22d. Yield: 0.070 g, 17 %, color-
less solid, m.p. > 285 °C (dec.). 1H NMR (600 MHz, [D6]DMSO): δ =
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4.59 (d, 1J = 6.0 Hz, 2H, H6′), 4.98 (dd, 1J = 17.1 Hz, 2J = 1.1 Hz, 1H,
H8′), 5.06 (dd, 1J = 10.3 Hz, 2J = 1.0 Hz, 1H, H8′), 5.63–5.56 (m, 1H,
H7′), 7.13 (d, 1J = 8.3 Hz, 1H, H8), 7.21–7.17 (m, 2H, H4′′), 7.24 (t,
1J = 7.3 Hz, 4H, H3′′), 7.31–7.28 (m, 2H), 7.32–7.28 (m, 5H, H2′′, H6),
7.45 (ddd, 1J = 8.6 Hz, 2J = 7.2 Hz, 3J = 1.6 Hz, 1H, H7), 7.79 (d, 1J =
2.0 Hz, 1H, H4′), 8.09 (dd, 1J = 7.9 Hz, 1J = 1.4 Hz, 1H, H8), 8.30 (d,
1J = 2.0 Hz, 1H, H5′) ppm. 13C NMR (151 MHz, [D6]DMSO): δ = 50.60
(C6′), 114.76 (C5′), 119.4 (C8), 119.96 (d, 2J = 1.7 Hz, C4a), 120.21
(C8′′), 124.76 (C6), 126.39 (C4′), 126.83 (C4′′), 127.52 (C5), 127.97
(C3′′), 130.73 (C7′), 133.07 (C7), 133.63 (C2′′), 141.83 (C8a), 142.26
(C1′′), 151.59 (d, 1J = 6.6 Hz, C2), 169.08 (C2′), 169.57 (d, 1J = 3.4 Hz,
C4) ppm. 11B NMR (193 MHz, [D6]DMSO): δ = –2.31 ppm. IR (ATR):
ν˜ = 3158, 3139, 3003, 1642, 1601, 1541, 1479, 1409, 1329, 1271,
1181, 984, 874, 768, 708, 632 cm–1. HRMS (ESI) m/z calcd. for
C26H21B15NN3ONa [M + Na]+ 440.1676, found 440.1681.
General Procedure for the Synthesis of the Borane Adducts
with Tris(pentafluorophenyl)borane B(C6F5)3 (23a–c): Under an
inert atmosphere a solution of 0.5 mmol of betaine and 2 equiv.
excess of tr is(pentafluorophenyl)borane B(C6F5)3 (512 mg,
1.0 mmol) in 20 mL of dry 1,4-dioxane was stirred at r.t. for 5 h in
a Schleck flask. Then, the solvent was evaporated in vacuo. The
resulting solid was purified by column chromatography (silica gel,
elution gradient petroleum ether → petroleum:ether/ethyl acetate,
1:2).
{[2-(1-Benzyl-1H-imidazol-3-ium-3-yl)quinazolin-4-yl]oxy}-
tris(perfluorophenyl)borate (23a): A sample of the betaine 13a
(151 mg, 0.5 mmol) was used. The adduct 23a was obtained as
colorless solid. Yield 0.228 g, 56 %, m.p. >207 °C (dec.). 1H NMR
(600 MHz, [D6]DMSO): δ = 5.50 (s, 2H, H6′), 7.43–7.39 (m, 3H, H9′,
H10′), 7.50–7.48 (m, 2H, H8′), 7.70 (ddd, 1J = 8.1 Hz, 2J = 7.0 Hz, 3J =
1.2 Hz, 1H, H6), 7.77 (t, 1J = 1.8 Hz, 1H, H5′), 7.83 (dd, 1J = 8.2 Hz,
2J = 0.8 Hz, 1H, H8), 7.93 (t, 1J = 1.9 Hz, 1H, H4′), 7.97 (ddd, 1J =
8.3 Hz, 2J = 6.9 Hz, 3J = 1.5 Hz, 1H, H7), 8.25 (dd, 1J = 8.2 Hz, 2J =
1.4 Hz, 1H, H5), 9.83 (t, 1J = 1.5 Hz, 1H, H2′) ppm. 13C NMR (151 MHz,
[D6]DMSO): δ = 52.64 (C6′), 118.20 (C4a), 118.28 (C5′), 121.30 (br. s,
C1′′), 123.38 (C4′), 125.17 (C5), 126.43 (C8), 127.52 (C6), 128.69 (C8′),
128.85 (C10′), 128.92 (C9′), 133.91 (C7), 134.95 (C7′), 135.14 (C2′),
135.94 (dm, 1J = 241.2 Hz, C2′′), 138.26 (dm, 1J = 244.5 Hz, C4′′),
147.32 (dm, 1J = 240.2 Hz, C3′′), 148.42 (C2), 149.85 (C8a), 170.16
(C4) ppm. 11B NMR (193 MHz, [D6]DMSO): δ = –3.16 ppm. 19F NMR
(400 MHz, [D6]DMSO): δ = –165.11 (t, 1J = 20.2 Hz, 2F, F3′′), –159.65
(t, 1J = 21.7 Hz, 1F, F4′′), –133.96 (d, 1J = 22.2 Hz, 2F, F2′′) ppm. IR
(ATR): ν˜ = 3674, 3176, 1644, 1595, 1514, 1447, 1381, 1275, 1080,
974, 931, 770, 747, 674, 624 cm–1. HRMS (ESI) m/z calcd. for
C36H13BF15N4O [M]– 813.0948, found 813.0946; elemental analysis
calcd. (%) for C36H14BF15N4O: C 53.10, H 1.73, N 6.88; found: C 52.98,
H 1.79, N 6.68.
{[2-(1-Methyl-1H-imidazol-3-ium-3-yl)quinazolin-4-yl]oxy}tris-
(perfluorophenyl)borate (23b): A sample of the betaine 13b
(113 mg, 0.5 mmol) was used. The adduct 23b was obtained as
colorless solid. Yield 0.177 g, 48 %, m.p. > 268 °C (dec.). 1H NMR
(600 MHz, [D6]DMSO): δ = 3.92 (s, 3H, 6′), 7.68–7.72 (m, 2H, H6, H5′),
7.81–7.83 (m, 1H, H8), 7.85 (t, 1J = 1.83 Hz, 1H, H4′), 7.97 (ddd, 1J =
8.4 Hz, 2J = 7.0 Hz, 3J = 1.5 Hz, 1H, H7), 8.25 (dd, 1J = 8.1 Hz, 2J =
1.0 MHz, 1H, H5), 9.70 (s, 1H, H2′) ppm. 13C NMR (151 MHz,
[D6]DMSO): δ = 36.39 (C6′), 117.42 (C5′), 118.2 (C4a), 121.2 (C1′′),
124.62 (C4′′), 125.20 (C5), 126.42 (C8), 127.50 (C6), 134.96 (C7),
135.82 (C2′), 136.00 (dm, 1J = 251 Hz, C2′′), 138.30 (dm, 1J = 250 Hz,
C4′′), 147.40 (dm, 1J = 242 Hz, C3′′), 148.40 (C2), 149.90 (C8a), 170.21
(C4) ppm. 11B NMR (193 MHz, [D6]DMSO): δ = –3.29 ppm. 19F NMR
(400 MHz, [D6]DMSO): δ = –165.16 (t, 1J = 20.4 Hz, 2F, F3′′), –159.60
(t, 1J = 21.6 Hz, 1F, F4′′), –133.97 (d, 1J = 22.8 Hz, 2F, F2′′) ppm. IR
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(ATR): ν˜ = 3180, 1644, 1598, 1508, 1454, 1381, 1278, 1172, 1093,
975, 930, 871, 811, 772, 758, 693, 623 cm–1. HRMS (ESI) m/z calcd.
for C30H9BF15N4O [M]– 737.0635, found 737.0645; elemental analysis
calcd. (%) for C30H10BF15N4O: C 48.81, H 1.37, N 7.59; found: C 48.99,
H 1.47, N 7.54.
{[2-(1-Methyl-1H-imidazol-3-ium-3-yl)quinazolin-4-yl]oxy}tris-
(perfluorophenyl)borate (*23b): A sample of the betaine *13b
(227 mg, 1.0 mmol) was used. The adduct *23b was obtained as
colorless solid. Yield 0.166 g, 45 %, m.p. > 268 °C (dec.). 1H NMR
(600 MHz, [D6]DMSO): δ = 3.92 (s, 3H, 6′), 7.73–7.68 (m, 2H, H6,
H5′), 7.82 (d, 1J = 8.3 Hz, 1H, H8), 7.85 (t, 1J = 1.8 Hz, 1H, H4′), 7.97
(ddd, 1J = 8.4 Hz, 2J = 7.1 Hz, 3J = 1.4 Hz, 1H, H7), 8.26 (dd, 1J =
8.2 Hz, 2J = 1.2 Hz, 1H, H5), 9.70 (s, 1H, H2′) ppm. 13C NMR (151 MHz,
[D6]DMSO): δ = 36.39 (C6′), 117.41 (C5′), 118.17 (C4a), 121.26 (br. s,
C1′′), 124.62 (C4′′), 125.18 (C5), 126.41 (C8), 127.50 (C6), 134.95 (C7),
135.83 (C2′), 135.99 (dm, 1J = 248 Hz, C2′′), 138.27 (dm, 1J = 247 Hz,
C4′′), 147.35 (dm, 1J = 241 Hz, C3′′), 148.40 (d, 1J = 5.9 Hz, C2),
149.87 (C8a), 170.2 (d, 1J = 7.5 Hz, C4) ppm. 11B NMR (193 MHz,
[D6]DMSO): δ = –3.61 ppm. 19F NMR (400 MHz, [D6]DMSO): δ =
–165.16 (t, 1J = 20.6 Hz, 2F, F3′′), –159.60 (t, 1J = 21.6 Hz, 1F, F4′′),
–134.00 (d, 1J = 22.8 Hz, 2F, F2′′) ppm. IR (ATR): ν˜ = 3180, 1644,
1598, 1508, 1454, 1381, 1278, 1172, 1093, 975, 930, 871, 811, 772,
758, 693, 623 cm–1. HRMS (ESI) m/z calcd. for C30H9BF15N315NO [M]–
738.0606, found 738.0568.
{[2-(1-Butyl-1H-imidazol-3-ium-3-yl)quinazolin-4-yl]oxy}tris-
(perfluorophenyl)borate (23c): A sample of the betaine 13c
(134 mg, 0.5 mmol) was used. The adduct 23c was obtained as
colorless solid. Yield 0.078 g, 20 %, m.p. > 247 °C (dec.). 1H NMR
(600 MHz, [D6]DMSO): δ = 0.90 (t, 1J = 7.4 Hz, 3H, H9′), 1.33–1.25
(m, 2H, H8′), 1.85–1.78 (m, 2H, H7′), 4.25 (t, 1J = 7.2 Hz, 2H, H6′),
7.70 (t, 1J = 7.6 Hz, 1H, H6), 7.77 (s, 1H, H5′), 7.83 (d, 1J = 8.3 Hz,
1H, H8), 8.00–7.95 (m, 2H, H4′, H7), 8.26 (d, 1J = 8.1 Hz, 1H, H5), 9.70
(s, 1H, H2′) ppm. 13C NMR (151 MHz, [D6]DMSO): δ = 13.24 (C9′),
18.79 (C8′), 31.01 (C7′), 49.35 (C6′), 117.83 (C5′), 118.19 (C4a), 121.16
(C1′′), 123.38 (C4′), 125.19 (C5), 126.43 (C8), 127.52 (C6), 134.96 (C7),
135.07 (C2′), 135.91 (dm, 1J = 253.6 Hz, C2′′), 138.27 (dm, 1J =
248.5 Hz, C4′′), 147.34 (dm, 1J = 245.6 Hz, C3′′), 148.44 (C2), 149.87
(C8a), 170.19 (C4) ppm. 11B NMR (193 MHz, [D6]DMSO): δ =
–4.21 ppm. 19F NMR (400 MHz, [D6]DMSO): δ = –165.14 (t, 1J =
20.5 Hz, 2F, F3′′) –159.65 (t, 1J = 21.6 Hz, 1F, F4′′), –133.98 (d, 1J =
22.4 Hz, 1F, F2′′) ppm. IR (ATR): ν˜ = 3351, 3148, 2968, 1598, 1559,
1510, 1454, 1362, 1280, 1220, 1087, 977, 932, 814, 772, 756, 697,
674, 620 cm–1. HRMS (ESI) m/z calcd. for C33H15BF15N4O [M]–
779.1105, found 779.1108.
Acknowledgments
This work was supported by the Russian Ministry of Education
and Science (State contract 4.6351.2017/8.9) and the Russian
Foundation for Basic Research (grant 17-03-01029). Single crys-
tal X-ray analysis of 23b was performed at the User Facilities
Centers of IGIC RAS within the State Assignment on Fundamen-
tal Research to the Kurnakov Institute of General and Inorganic
Chemistry. We thank the Deutscher Akademischer Austausch-
dienst DAAD for the financial support of the internship of
S. D. at Clausthal University of Technology, Germany.
Keywords: Anionic NHCs · Betaines · Boron compounds ·
Carbenes · Cyclic borates · Imidazol-2-ylidene
Communication
[1] A. J. Arduengo III, R. L. Harlow, M. Kline, J. Am. Chem. Soc. 1991, 113,
361–363.
[2] a) N-Heterocyclic Carbenes in Organocatalysis (Ed.: A. T. Biju), Wiley-VCH,
Weinheim, 2019; b) N-Heterocyclic Carbenes: Effective Tools for Organo-
metallic Synthesis (Ed.: S. P. Nolan), Wiley-VCH, 2014.
[3] a) Science of Synthesis: N-Heterocyclic Carbenes in Catalytic Organic Syn-
thesis (Eds.: S. P. Nolan, C. S. J. Cazin), Thieme Verlag, Stuttgart, 2017; b)
N-Heterocyclic Carbenes in Transition Metal Catalysis (Topics in Organo-
metallic Chemistry, vol. 21), (Ed.: F. Glorius), Springer, Berlin, 2010.
[4] a) N. Merceron-Saffon, A. Baceiredo, H. Gornitzka, G. Bertrand, Science
2003, 301, 1223–1225; b) F. E. Hahn, M. C. Jahnke, Angew. Chem. Int. Ed.
2008, 47, 3122–3171; Angew. Chem. 2008, 120, 3166; c) S. Budagumpi,
R. A. Haque, S. Endud, G. U. Rehman, A. W. Salman, Eur. J. Inorg. Chem.
2013, 4367–4388; d) C. Hille, F. E. Kühn, Dalton Trans. 2016, 45, 15–31;
e) A. H. Sandtorv, C. Leitch, S. L. Bedringaas, B. T. Gjertsen, H.-R. Bjørsvik,
ChemMedChem 2015, 10, 1522–1527; f ) A. Nasr, A. Winkler, M. Tamm,
Coord. Chem. Rev. 2016, 316, 68–124; g) C. I. Ezugwu, N. A. Kabir, M.
Yusubov, F. Verpoort, Coord. Chem. Rev. 2016, 307, 188–210; h) Y. Ohki,
H. Seino, Dalton Trans. 2016, 45, 874–880; i) V. Ritleng, M. Henrion, M. J.
Chetcuti, ACS Catal. 2016, 6, 890–906; j) A. Schmidt, S. Wiechmann, C. F.
Otto, Adv. Heterocycl. Chem. 2016, 119, 143–172.
[5] A. Doddi, M. Peters, M. Tamm, Chem. Rev. 2019, 119, 6994–7112.
[6] C. A. Smith, M. R. Narouz, P. A. Lummis, I. Singh, A. Nazemi, C.-H. Li, C. M.
Crudden, Chem. Rev. 2019, 119, 4986–5056.
[7] S. Kumar, J. Heterocycl. Chem. 2019, 56, 1168–1230.
[8] J. Lee, H. Hahm, J. Kwak, M. Kim, Adv. Synth. Catal. 2019, 361, 1479–1499.
[9] A. A. Danopoulos, T. Simler, P. Braunstein, Chem. Rev. 2019, 119, 3730–
3961.
[10] V. Lavallo, Y. Canac, C. Präsang, B. Donnadieu, G. Bertrand, Angew. Chem.
Int. Ed. 2005, 44, 5705–5709; Angew. Chem. 2005, 117, 5851.
[11] J. A. M. Lummiss, C. S. Higman, D. L. Fyson, R. McDonald, D. E. Fogg,
Chem. Sci. 2015, 6, 6739–6746.
[12] A. Schmidt, S. Wiechmann, T. Freese, ARKIVOC 2013, i, 424–469.
[13] A. Ferry, K. Schaepe, P. Tegeder, C. Richter, K. M. Chepiga, B. J. Ravoo, F.
Glorius, ACS Catal. 2015, 5, 5414–5420.
[14] a) V. César, V. Mallardo, A. Nano, G. Dahm, N. Lugan, G. Lavigne, S. Bel-
lemin-Laponnaz, Chem. Commun. 2015, 51, 5271–5274; b) L. Benhamou,
N. Vujkovic, V. César, H. Gornitzka, N. Lugan, G. Lavigne, Organometallics
2010, 29, 2616–2630; c) L. Benhamou, V. César, H. Gornitzka, N. Lugan,
G. Lavigne, Chem. Commun. 2009, 4720–4722; d) A. T. Biju, K. Hirano, R.
Fröhlich, F. Glorius, Chem. Asian J. 2009, 4, 1786–1789.
[15] a) V. César, J.-C. Tourneux, N. Vujkovic, R. Brousses, N. Lugan, G. Lavigne,
Chem. Commun. 2012, 48, 2349–2351; b) A. A. Danopoulos, K. Yu.
Monakhov, P. Braunstein, Chem. Eur. J. 2013, 19, 450–455.
[16] S. Wiechmann, T. Freese, M. H. H. Drafz, E. G. Hübner, J. C. Namyslo, M.
Nieger, A. Schmidt, Chem. Commun. 2014, 50, 11822–11824.
[17] a) T. Freese, M. Nieger, J. C. Namyslo, A. Schmidt, Tetrahedron Lett. 2019,
60, 1272–1276; b) T. Freese, J. C. Namyslo, M. Nieger, A. Schmidt, RSC
Adv. 2019, 9, 4781–4788; c) T. Freese, A.-L. Lücke, J. C. Namyslo, M. Nieger,
A. Schmidt, Eur. J. Org. Chem. 2018, 1646–1654; d) T. Freese, A.-L. Lücke,
C. A. S. Schmidt, M. Polamo, M. Nieger, J. C. Namyslo, A. Schmidt, Tetra-
hedron 2017, 73, 5350–5357.
[18] N. Pidlypnyi, F. Uhrner, M. Nieger, M. H. H. Drafz, E. G. Hübner, J. C. Nam-
yslo, A. Schmidt, Eur. J. Org. Chem. 2013, 7739–7748.
[19] a) G. Lavigne, V. César, N. Lugan, Chem. Eur. J. 2010, 16, 11432–11442;
b) V. César, N. Lugan, G. Lavigne, J. Am. Chem. Soc. 2008, 130, 11286–
11287.
[20] a) H. Gotthardt, J. Blum, Chem. Ber. 1987, 120, 115–117; b) K. Potts, M.
Sorm, J. Org. Chem. 1972, 37, 1422–1425.
[21] W. P. Oziminski, C. A. Ramsden, RSC Adv. 2018, 8, 14833–14837.
[22] C. A. Ramsden, W. P. Oziminski, J. Org. Chem. 2017, 82, 12485–12491.
[23] a) R. Breslow, J. Am. Chem. Soc. 1958, 80, 3719–3726; b) H. Quast, E.
Schmitt, Justus Liebigs Ann. Chem. 1970, 732, 43–63; c) A. R. Katritzky,
H. M. Faid-Allah, Synthesis 1983, 149–150; d) D. Lavorato, J. K. Terlouw,
T. K. Dargel, W. Koch, G. A. McGibbon, H. Schwarz, J. Am. Chem. Soc.
1996, 118, 11898–11904.
[24] a) A. Schmidt, A. Beutler, M. Albrecht, F. J. Ramírez, Org. Biomol. Chem.
2008, 6, 287–295; b) M. Fèvre, J. Pinaud, A. Leteneur, Y. Gnanou, J. Vi-
gnolle, D. Taton, K. Miqueu, J.-M. Sotiropoulos, J. Am. Chem. Soc. 2012,
134, 6776–6784; c) X. Sauvage, A. Demonceau, L. Delaude, Adv. Synth.
Eur. J. Org. Chem. 2020, 450–465 www.eurjoc.org © 2019 The Authors. Published by Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim464
Catal. 2009, 351, 2031–2038; d) E. L. Kolychev, T. Bannenberg, M. Freytag,
C. G. Daniliuc, P. G. Jones, M. Tamm, Chem. Eur. J. 2012, 18, 16938–16946.
[25] a) A. Schmidt, N. Münster, A. Dreger, Angew. Chem. Int. Ed. 2010, 49,
2790–2793; Angew. Chem. 2010, 122, 2851; b) A. Schmidt, T. Habeck, Lett.
Org. Chem. 2005, 2, 37–39.
[26] a) Z. Guan, S. Wiechmann, M. Drafz, E. Hübner, A. Schmidt, Org. Biomol.
Chem. 2013, 11, 3558–3567; b) A. Schmidt, L. Merkel, W. Eisfeld, Eur. J.
Org. Chem. 2005, 2124–2130.
[27] C. Färber, M. Leibold, C. Bruhn, M. Maurer, U. Siemeling, Chem. Commun.
2012, 48, 227–229.
[28] a) J. Zhang, E. G. Hübner, J. C. Namyslo, M. Nieger, A. Schmidt, Org.
Biomol. Chem. 2018, 16, 6801–6808; b) A.-L. Lücke, S. Wiechmann, T.
Freese, M. Nieger, T. Földes, I. Pápai, M. Gjikaj, A. Adam, A. Schmidt,
Tetrahedron 2018, 74, 2092–2099; c) J. Zhang, M. Franz, E. Hübner, A.
Schmidt, Tetrahedron 2016, 72, 525–531; d) N. Pidlypnyi, J. C. Namyslo,
M. H. H. Drafz, M. Nieger, A. Schmidt, J. Org. Chem. 2013, 78, 1070–1079;
e) A. Dreger, R. Cisneros Camuña, N. Münster, T. A. Rokob, I. Pápai, A.
Schmidt, Eur. J. Org. Chem. 2010, 4296–4305; f ) A. Schmidt, B. Snovydo-
vych, S. Hemmen, Eur. J. Org. Chem. 2008, 4313–4320.
[29] a) P. K. Chaudhuri, Phytochemistry 1987, 26, 587–589; b) M. F. Grundon,
Nat. Prod. Rep. 1988, 5, 293–307; c) J. P. Michael, Nat. Prod. Rep. 2008,
25, 166–187.
[30] a) R. F. Richard, J. P. Sharman, S. E. Coutre, B. D. Cheson, J. M. Pagel, P.
Hillmen, J. C. Barrientos, A. D. Zelenetz, T. J. Kipps, I. Flinn, P. Ghia, H.
Eradat, T. Ervin, N. Lamanna, B. Coiffier, A. R. Pettitt, S. Ma, S. Stilgenbauer,
P. Cramer, M. Aiello, D. M. Johnson, L. L. Miller, D. Li, T. M. Jahn, R. D.
Dansey, M. Hallek, S. M. O′Brien, N. Engl. J. Med. 2014, 370, 997–1007; b)
C. Shustik, I. Bence-Bruckler, R. Delage, C. J. Owen, C. L. Toze, S. Coutre,
Ann. Hematol. 2017, 96, 1185–1196.
[31] a) T. Ochiai, R. Ishida, Jpn. J. Pharmacol. 1981, 31, 491–501; b) I. Khan, A.
Ibrar, N. Abbas, A. Saeed, Eur. J. Med. Chem. 2014, 76, 193–244.
[32] S. Seyedmousavi, P. E. Verweij, J. W. Mouton, Expert Rev. Anti-Infect. Ther.
2015, 13, 9–27.
[33] a) S. M. Bakalova, A. G. Santos, I. Timcheva, J. Kaneti, I. L. Filipova, G. M.
Dobrikov, V. D. Dimitrov, THEOCHEM 2004, 710, 229–234; b) T. V. Trashak-
hova, E. V. Nosova, M. S. Valova, P. A. Slepukhin, G. N. Lipunova, V. N.
Charushin, Russ. J. Org. Chem. 2011, 47, 753–761.
[34] a) C. A. Ramsden, Tetrahedron 2013, 69, 4146–4151; b) C. A. Ramsden,
W. P. Oziminski, Tetrahedron 2014, 70, 7158–7165; c) W. P. Oziminski, C. A.
Ramsden, Tetrahedron 2015, 71, 7191–7198; d) W. D. Ollis, S. P. Stanforth,
C. A. Ramsden, Tetrahedron 1985, 41, 2239–2329.
[35] K. Verlinden, H. Buhl, W. Frank, C. Ganter, Eur. J. Inorg. Chem. 2015, 2416–
2425.
[36] A. V. Afonin, D. V. Pavlov, A. V. Vashchenko, J. Mol. Struct. 2019, 1176, 73–
85.
[37] a) T. Hölzel, M. Otto, H. Buhl, C. Ganter, Organometallics 2017, 36, 4443–
4450; b) H. Buhl, C. Ganter, Chem. Commun. 2013, 49, 5417–5419.
[38] A. Liske, K. Verlinden, H. Buhl, K. Schaper, C. Ganter, Organometallics
2013, 32, 5269–5272.
[39] a) D. J. Nelson, A. Collado, S. Manzini, S. Meiries, A. M. Z. Slawin, D. B.
Cordes, S. P. Nolan, Organometallics 2014, 33, 2048–2058; b) D. J. Nelson,
F. Nahra, S. R. Patrick, D. B. Cordes, A. M. Z. Slawin, S. P. Nolan, Organome-
tallics 2014, 33, 3640–3645; c) S. V. C. Vummaleti, D. J. Nelson, A. Poater,
A. Gómez-Suárez, D. B. Cordes, A. M. Z. Slawin, S. P. Nolan, L. Cavallo,
Chem. Sci. 2015, 6, 1895–1904.
[40] S. L. Deev, I. A. Khalymbadzha, T. S. Shestakova, V. N. Charushin, O. N.
Chupakhin, RSC Adv. 2019, 9, 26856–26879.
[41] B. Wrackmeyer, O. L. Tok, Z. Naturforsch. B 2007, 62, 220–224.
[42] M. Liu, J. C. Namyslo, M. Nieger, M. Polamo, A. Schmidt, Beilstein J. Org.
Chem. 2016, 12, 2673–2681.
[43] T. Zhao, X. Hu, Y. Wu, Z. Zhang, Angew. Chem. Int. Ed. 2019, 58, 722–726;
Angew. Chem. 2019, 131, 732.
[44] N. G. Kim, C. H. Shin, M. H. Lee, Y. Do, J. Organomet. Chem. 2009, 694,
1922–1928.
[45] D. P. Curran, A. Solovyev, M. M. Brahmi, L. Fensterbank, M. Malacria, E.
Lacîte, Angew. Chem. Int. Ed. 2011, 50, 10294–10317; Angew. Chem. 2011,
123, 10476.
[46] G. M. Sheldrick, SHELXS-97, a Program for the Automatic Solution of Crys-
tal Structures; University of Göttingen, Göttingen, Germany, 1997.
Communication
[47] G. M. Sheldrick, SHELXL-97, a Program for Crystal Structure Refinement;
University of Göttingen, Göttingen, Germany, 1997.
[48] L. Krause, R. Herbst-Irmer, G. M. Sheldrick, D. Stalke, J. Appl. Crystallogr.
2015, 48, 3–10.
[49] G. M. Sheldrick, Acta Crystallogr., Sect. A 2015, 71, 3–8.
Eur. J. Org. Chem. 2020, 450–465 www.eurjoc.org © 2019 The Authors. Published by Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim465
[50] F. Samrin, A. Sharma, I. A. Khan, S. Puri, J. Heterocycl. Chem. 2012, 49,
1391–1397.
Received: November 4, 2019
